KR101527181B1 - Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same - Google Patents

Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same Download PDF

Info

Publication number
KR101527181B1
KR101527181B1 KR1020120151964A KR20120151964A KR101527181B1 KR 101527181 B1 KR101527181 B1 KR 101527181B1 KR 1020120151964 A KR1020120151964 A KR 1020120151964A KR 20120151964 A KR20120151964 A KR 20120151964A KR 101527181 B1 KR101527181 B1 KR 101527181B1
Authority
KR
South Korea
Prior art keywords
substituted
unsubstituted
group
compound
mol
Prior art date
Application number
KR1020120151964A
Other languages
Korean (ko)
Other versions
KR20130136366A (en
Inventor
현서용
윤용호
송정한
Original Assignee
(주)피엔에이치테크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)피엔에이치테크 filed Critical (주)피엔에이치테크
Priority to PCT/KR2013/002321 priority Critical patent/WO2013183851A1/en
Priority to CN201380038179.3A priority patent/CN104471021B/en
Publication of KR20130136366A publication Critical patent/KR20130136366A/en
Application granted granted Critical
Publication of KR101527181B1 publication Critical patent/KR101527181B1/en

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05BELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B33/00Electroluminescent light sources
    • H05B33/12Light sources with substantially two-dimensional radiating surfaces
    • H05B33/14Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material, or by the simultaneous addition of the electroluminescent material in or onto the light source
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

하기 구조식 1 또는 2로 표시되는 유기전계발광소자용 화합물 및 그를 포함하는 유기전계발광소자가 개시된다. 이에 의하여, 전기적 안정성 및 전자와 정공 수송능력이 우수하며, 삼중항 상태 에너지가 높아 인광발광재료의 발광효율을 향상 시킬 수 있는 호스트, 정공수송물질 및 전자수송 물질로 사용할 수 있는 유기발광소자용 화합물 및 유기전계발광소자를 제공할 수 있다.

Figure 112012107028500-pat00161
An organic electroluminescent device compound represented by the following structural formula 1 or 2 and an organic electroluminescent device comprising the same are disclosed. As a result, it is possible to provide a compound for an organic light emitting device that can be used as a host, a hole transporting material, and an electron transporting material, which is excellent in electrical stability, electron and hole transporting ability and high in triplet state energy, And an organic electroluminescent device.
Figure 112012107028500-pat00161

Description

새로운 유기전계발광소자용 화합물 및 그를 포함하는 유기전계발광소자{NOVEL COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME}TECHNICAL FIELD [0001] The present invention relates to a compound for a novel organic electroluminescent device and an organic electroluminescent device including the same. BACKGROUND OF THE INVENTION [0002]

본 발명은 유기전계발광소자용 화합물 및 그를 포함하는 유기전계발광소자에 관한 것으로, 보다 상세하게는 유기전계발광소자의 발광효율을 향상시킬 수 있는 유기전계발광소자용 화합물 및 그를 포함하는 유기전계발광소자에 관한 것이다.BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a compound for an organic electroluminescent device and an organic electroluminescent device including the same, and more particularly to a compound for an organic electroluminescent device capable of improving the luminous efficiency of the organic electroluminescent device, Device.

정보화 사회로의 움직임이 가속화되면서 평판 디스플레이의 비중이 점차 증가하고 있다. 그 중 LCD(liquid crystal display)가 현재 가장 많이 쓰이고 있지만 액정에 전압을 가해 백라이트로부터의 빛을 컬러필터로 통과시켜 삼원색을 얻음으로써 화면을 만드는 방식이며, 유기EL(OLED; Organic Light Emitting Diodes)은 자체발광 소자로써 시야각 및 대조비 등이 우수하고, 경량 및 박형이 가능하며 휘는 성질의 기판에도 사용할 수 있어, 투명, 플렉서블 디스플레이가 가능하여 차세대 표시소자로서 주목을 받고 있다.As the move to the information society accelerates, the proportion of flat panel displays is gradually increasing. LCD (liquid crystal display) is the most widely used method, but it is a method to make a screen by applying voltage to liquid crystal and passing light from backlight through color filter to obtain three primary colors. Organic light emitting diodes (OLED) As a self-luminous element, it has excellent viewing angle and contrast ratio, is lightweight and thin, can be used for a substrate having a bending property, and is capable of transparent and flexible display, and has attracted attention as a next generation display element.

유기EL은 유기물 박막에 음극과 양극을 통하여 주입된 전자와 정공이 재결합을 통해 여기자를 형성하고, 형성된 그 여기자로부터 특정한 파장의 빛이 발생하는 현상으로 1963년 Pope 등에 의해 안트라센(anthracene)의 단결정으로부터 처음으로 발견되었고 이후 이스트만 코닥사의 탕(C.W Tang)등에 의해 적층형의 유기EL 소자의 보고(C.W Tang, S.A Vanslyke, Applied physics Letters. 51권 913p, 1987) 된 이후 활발히 연구되고 있다.Organic EL is a phenomenon in which excitons are formed by recombination of electrons and holes injected through a cathode and an anode into an organic thin film, and light of a specific wavelength is generated from the excitons formed. In 1963, Pope et al. Reported that an anthracene single crystal (CW Tang, SA Vanslyke, Applied Physics Letters, Vol. 51, No. 913p, 1987) by Eastman Kodak Co., Ltd. (CW Tang) et al.

유기전계발광소자에 사용되는 유기물질은 크게 고분자와 저분자 형태로 나누어 지며 저분자는 순 유기물질과 메탈과 킬레이트를 형성한 메탈 콤플렉스로 나뉘어질 수 있다.Organic materials used in organic electroluminescent devices are classified into polymer and small molecule, and small molecules can be divided into pure organic material and metal complex which forms metal and chelate.

고분자 물질은 다양한 기능의 유닛을 고분자 체인에 결합하여 다 기능의 물질을 만들어 낼 수 있으나, 합성물 정제시나 소자 형성 시 어려움이 있고, 저분자 물질은 각 특성의 물질을 합성 할 수 있으나 다 기능의 특성을 나타내는 물질 합성에는 한계가 있다 하겠다. Polymers can combine diverse functional units into polymer chains to produce multifunctional materials. However, it is difficult to purify compounds or to form devices, while low-molecular materials can synthesize materials of various properties. There is a limit to the synthesis of the substances.

유기전계발광소자를 적층구조로 형성할 수 있다. 적층구조의 장점으로는 각 기능에 맞게끔 물질을 선택하여 사용 할 수 있는 것인데, 일반적으로 소자구조는 양극과 음극 사이에 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층을 형성하여 발광층에서 여기자 형성을 쉽게 하게 하고, 발광 효율을 높일 수 있다.The organic electroluminescent device can be formed in a laminated structure. In general, the device structure is formed by forming a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer between an anode and a cathode to form a light emitting layer It is possible to facilitate the formation of excitons and increase the luminous efficiency.

발광물질은 호스트물질과 발광물질(도판트)물질로 크게 나눌 수 있고, 발광물질은 발광 기작에 따라 형광과 인광으로 구별된다. The luminescent material can be roughly divided into a host material and a luminescent material (dopant) material, and the luminescent material is distinguished by fluorescence and phosphorescence depending on the luminescence mechanism.

화합물 내 전자의 여기 상태는 일중항 대 삼중항의 비율이 1:3으로 삼중항 상태가 3배 정도 더 생성된다. 따라서, 일중항 상태에서 기저상태로 떨어지는 형광의 내부양자효율이 25%에 그치는 반면 삼중항 상태에서 기저상태로 떨어지는 인광의 내부양자효율은 75%이다. 또한 일중항 상태에서 삼중항 상태로 계간전이가 일어날 경우 내부양자효율의 이론적 한계치는 100%에 달한다. 이러한 점을 이용해 발광효율을 개선한 발광재료가 인광 발광재료이다.The excited state of the electrons in the compound is 1: 3 ratio of singlet to triplet, and triplet state is generated about 3 times more. Thus, the internal quantum efficiency of phosphorescence falling from the triplet state to the base state is 75% while the internal quantum efficiency of the fluorescence falling from the singlet state to the ground state is only 25%. In addition, the theoretical limit of internal quantum efficiency reaches 100% when the interplanar transition from singlet state to triplet state occurs. A light emitting material that improves the light emitting efficiency by using this point is a phosphorescent material.

유기물의 특성상 인광 발광은 어려움이 있어, 인광 발광재료로는 전이금속(이리듐)을 이용환 유기금속화합물이 개발되고 있으며, 이를 보조하는 호스트 물질로 유기물질이 이용되고 있다. 인광발광물질을 보조하는 물질(호스트)는 밴드갭이 넓고 상중항 상태 에너지가 높아야 한다. 전류효율과 발광효율이 우수한 인광물질이 각광을 받고 있으나 전자 수송능력과 정공 수송능력, 열적, 전기적으로 안전하고, 특히 삼중항 상태의 에너지가 높은 호스트 물질이 없어 개발이 시급하다.Due to the nature of organic materials, it is difficult to emit phosphorescence. As a phosphorescent material, transition metal (iridium) is utilized as an organometallic compound, and an organic material is used as a host material to assist it. The material that assists the phosphorescent material (host) should have a wide bandgap and a high half-energy state energy. Although the phosphorescent material having excellent current efficiency and luminous efficiency is in the spotlight, development is urgent because there is no electron transporting ability, hole transporting ability, thermal and electrical safety, and particularly, host material having high energy of triplet state.

본 발명은 전기적 안정성 및 전자와 정공 수송능력이 우수하며, 삼중항 상태 에너지가 높아 인광발광재료의 발광효율을 향상시킬 수 있는 호스트로서 발광층에 사용될 수 있는 유기발광소자용 화합물 및 이를 포함하는 유기전계발광소자를 제공할 수 있다.The present invention relates to a compound capable of being used for a light emitting layer as a host which is excellent in electrical stability, electron and hole transporting ability, and has high triplet state energy and can improve the luminous efficiency of a phosphorescent light emitting material, A light emitting element can be provided.

또한 본 발명은 유기전계발광소자의 전자수송재료나, 정공수송재료에 사용될 수 있는 유기발광소자용 화합물 및 이를 포함하는 유기전기 발광소자를 제공할 수 있다.In addition, the present invention can provide an organic electroluminescent compound that can be used for an electron transporting material and a hole transporting material of an organic electroluminescent device, and an organic electroluminescent device including the same.

그러나, 본원이 해결하고자 하는 과제는 이상에서 언급한 과제로 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.However, the problems to be solved by the present invention are not limited to the above-mentioned problems, and other problems not mentioned can be clearly understood by those skilled in the art from the following description.

본 발명의 일 측면에 따르면, 하기 구조식 1 또는 2로 표시되는 유기전계발광소자용 화합물이 제공될 수 있다.According to an aspect of the present invention, there is provided a compound for an organic electroluminescence device represented by the following structural formula 1 or 2:

Figure 112012107028500-pat00001
Figure 112012107028500-pat00001

상기 구조식 1 또는 2에서,In the above structural formula 1 or 2,

R4 내지 R6은 서로 같거나 다를 수 있고, R4 내지 R6은 각각 독립적으로 수소원자,

Figure 112012107028500-pat00002
,
Figure 112012107028500-pat00003
,
Figure 112012107028500-pat00004
,
Figure 112012107028500-pat00005
,
Figure 112012107028500-pat00006
,
Figure 112012107028500-pat00007
, ,
Figure 112012107028500-pat00009
,
Figure 112012107028500-pat00010
,
Figure 112012107028500-pat00011
,
Figure 112012107028500-pat00012
,
Figure 112012107028500-pat00013
,
Figure 112012107028500-pat00014
,
Figure 112012107028500-pat00015
,
Figure 112012107028500-pat00016
,
Figure 112012107028500-pat00017
,
Figure 112012107028500-pat00018
,
Figure 112012107028500-pat00019
,
Figure 112012107028500-pat00020
,
Figure 112012107028500-pat00021
,
Figure 112012107028500-pat00022
,
Figure 112012107028500-pat00023
,
Figure 112012107028500-pat00024
, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C1 내지 C30 헤테로아릴기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기이거나, 또는 R4 내지 R6중 적어도 어느 하나는 그 어느 하나가 결합된 탄소원자의 이웃한 탄소원자와 추가로 결합하여 치환 또는 비치환된 융합된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 융합된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 융합된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 융합된 C1 내지 C30 헤테로 아릴기를 형성할 수 있고,R 4 to R 6 may be the same or different from each other, and R 4 to R 6 are each independently a hydrogen atom,
Figure 112012107028500-pat00002
,
Figure 112012107028500-pat00003
,
Figure 112012107028500-pat00004
,
Figure 112012107028500-pat00005
,
Figure 112012107028500-pat00006
,
Figure 112012107028500-pat00007
, ,
Figure 112012107028500-pat00009
,
Figure 112012107028500-pat00010
,
Figure 112012107028500-pat00011
,
Figure 112012107028500-pat00012
,
Figure 112012107028500-pat00013
,
Figure 112012107028500-pat00014
,
Figure 112012107028500-pat00015
,
Figure 112012107028500-pat00016
,
Figure 112012107028500-pat00017
,
Figure 112012107028500-pat00018
,
Figure 112012107028500-pat00019
,
Figure 112012107028500-pat00020
,
Figure 112012107028500-pat00021
,
Figure 112012107028500-pat00022
,
Figure 112012107028500-pat00023
,
Figure 112012107028500-pat00024
, A substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C1 to C30 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, Or a fused C3 to C30 cycloalkyl group which is further substituted or unsubstituted by at least any one of R 4 to R 6 bonded to the adjacent carbon atom of the carbon atom to which at least any one of R 4 to R 6 is bonded, A substituted or unsubstituted fused C1 to C30 heterocycloalkyl group, a substituted or unsubstituted fused C6 to C30 aryl group, or a substituted or unsubstituted fused C1 to C30 heteroaryl group,

X1 내지 X37은 서로 같거나 다를 수 있고, X1 내지 X37은 각각 독립적으로 질소원자, 또는

Figure 112012107028500-pat00025
이고,X 1 to X 37 may be the same or different from each other, X 1 to X 37 each independently represents a nitrogen atom, or
Figure 112012107028500-pat00025
ego,

Y1 내지 Y13은 서로 같거나 다를 수 있고, Y1 내지 Y13은 각각 독립적으로 산소원자, 황원자,

Figure 112012107028500-pat00026
, 또는
Figure 112012107028500-pat00027
이고,Y 1 to Y 13 may be the same or different from each other, and Y 1 To Y 13 each independently represent an oxygen atom, a sulfur atom,
Figure 112012107028500-pat00026
, or
Figure 112012107028500-pat00027
ego,

R8 내지 R70은 서로 같거나 다를 수 있고, R8 내지 R70은 각각 독립적으로 수소원자,

Figure 112012107028500-pat00028
,
Figure 112012107028500-pat00029
,
Figure 112012107028500-pat00030
,
Figure 112012107028500-pat00031
, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고, 또는 R8 내지 R70중 적어도 어느 하나는 그 어느 하나가 결합된 탄소원자의 이웃한 탄소원자와 추가로 결합하여 치환 또는 비치환된 융합된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 융합된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 융합된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 융합된 C1 내지 C30 헤테로 아릴기를 형성할 수 있고,R 8 to R 70 may be the same or different from each other, and R 8 to R 70 each independently represent a hydrogen atom,
Figure 112012107028500-pat00028
,
Figure 112012107028500-pat00029
,
Figure 112012107028500-pat00030
,
Figure 112012107028500-pat00031
, A substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, Or a fused C3 to C30 cycloalkyl group which is further substituted or unsubstituted by at least any one of R 8 to R 70 bonded to a neighboring carbon atom of a carbon atom to which any one of R 8 to R 70 is bonded, A substituted or unsubstituted fused C1 to C30 heterocycloalkyl group, a substituted or unsubstituted fused C6 to C30 aryl group, or a substituted or unsubstituted fused C1 to C30 heteroaryl group,

Ar3 내지 Ar7은 서로 같거나 다를 수 있고, Ar3 내지 Ar7은 각각 독립적으로

Figure 112012107028500-pat00032
,
Figure 112012107028500-pat00033
,
Figure 112012107028500-pat00034
,
Figure 112012107028500-pat00035
, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,Ar 3 to Ar 7 may be the same or different from each other, Ar 3 to Ar 7 each independently represent
Figure 112012107028500-pat00032
,
Figure 112012107028500-pat00033
,
Figure 112012107028500-pat00034
,
Figure 112012107028500-pat00035
, A substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, RTI ID = 0.0 > Cl-C30 < / RTI > heteroaryl group,

Ar1 및 Ar2는 서로 같거나 다를 수 있고, Ar1 및 Ar2는 각각 독립적으로

Figure 112012107028500-pat00036
,
Figure 112012107028500-pat00037
,
Figure 112012107028500-pat00038
,
Figure 112012107028500-pat00039
,
Figure 112012107028500-pat00040
, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이거나, 또는 Ar1 및 Ar2는 서로 결합되고 그들 사이의 질소원자와 함께 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기를 형성할 수 있고,Ar 1 and Ar 2 may be the same or different from each other, Ar 1 and Ar 2 are each independently
Figure 112012107028500-pat00036
,
Figure 112012107028500-pat00037
,
Figure 112012107028500-pat00038
,
Figure 112012107028500-pat00039
,
Figure 112012107028500-pat00040
, A substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, C1 to C30 heteroaryl group, or is Ar 1 and Ar 2 are combined and together with the nitrogen atom between them, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, or form a substituted or unsubstituted C1-C30 heteroaryl each other You can,

X38 내지 X40은 서로 같거나 다를 수 있고, X38 내지 X40은 각각 독립적으로 질소원자, 또는

Figure 112012107028500-pat00041
이고,X 38 to X 40 may be the same or different from each other, and each of X 38 to X 40 is independently a nitrogen atom or
Figure 112012107028500-pat00041
ego,

Y14 내지 Y17은 서로 같거나 다를 수 있고, Y14 내지 Y17은 각각 독립적으로 산소원자, 황원자,

Figure 112012107028500-pat00042
, 또는
Figure 112012107028500-pat00043
이고,Y 14 to Y 17 may be the same or different from each other, Y 14 to Y 17 represents an oxygen atom, a sulfur atom, each independently,
Figure 112012107028500-pat00042
, or
Figure 112012107028500-pat00043
ego,

R71 내지 R116은 서로 같거나 다를 수 있고, R71 내지 R116은 서로 독립적으로 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,R 71 To R < 116 > may be the same or different from each other, and R < 71 > To R < 116 > independently represent a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group , Or a substituted or unsubstituted C1 to C30 heteroaryl group,

Ar8은 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,Ar 8 represents a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, An unsubstituted C1 to C30 heteroaryl group,

R1 내지 R3, 및 R7은 서로 같거나 다를 수 있고, R1 내지 R3, 및 R7은 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이거나, 또는 R1 내지 R3, 및 R7 중 적어도 어느 하나는 그 어느 하나가 결합된 탄소원자의 이웃한 탄소원자와 추가로 결합하여 치환 또는 비치환된 융합된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 융합된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 융합된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 융합된 C1 내지 C30 헤테로 아릴기를 형성할 수 있다.R 1 to R 3 and R 7 may be the same or different from each other, and R 1 to R 3 and R 7 are each independently a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 aryl group, C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C1 to C30 heteroaryl group, or R 1 to R 3 and R 7 At least one of them is a fused C3 to C30 cycloalkyl group, a substituted or unsubstituted fused C1 to C30 heterocycloalkyl group, a substituted or unsubstituted fused C3 to C30 heterocycloalkyl group, Or an unsubstituted fused C6 to C30 aryl group, or a substituted or unsubstituted fused C1 to C30 heteroaryl group.

상기 치환 또는 비치환된 C6 내지 C30 아릴기의 예는 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 터페닐기, 치환 또는 비치환된 나프탈레닐기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 스파이로플루오레닐기, 치환 또는 비치환된 파이레닐기, 또는 치환 또는 비치환된 페릴레닐기일 수 있다.Examples of the substituted or unsubstituted C6 to C30 aryl group include a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthalenyl group, a substituted or unsubstituted naphthalenyl group, A substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted spirobifluorenyl group, a substituted or unsubstituted pyrenyl group, or a substituted or unsubstituted furanyl group, Lt; / RTI >

상기 치환 또는 비치환된 C2 내지 C30 헤테로아릴기의 예는 치환 또는 비치환된 피리디닐기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 싸이오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 벤조싸이오페닐기, 치환 또는 비치환된 인돌릴기, 치환 또는 비치환된 이미다조[1,2-a]피리디닐기, 치환 또는 비치환된 벤지이미다졸릴기, 치환 또는 비치환된 인다졸릴기, 치환 또는 비치환된 페노티아지닐기, 치환 또는 비치환된 페나지닐기, 치환 또는 비치환된 카바졸릴기, 치환 또는 비치환된 디벤조싸이오페닐기, 치환 또는 비치환된 이미다졸릴기, 치환 또는 비치환된 트리아졸릴기, 치환 또는 비치환된 테트라졸릴기, 치환 또는 비치환된 옥사다이아졸릴기, 치환 또는 비치환된 옥사트리아졸릴기, 치환 또는 비치환된 싸이아트리아졸릴기, 치환 또는 비치환된 벤조트리아졸릴기, 치환 또는 비치환된 피라지닐기, 치환 또는 비치환된 피리다지닐기, 치환 또는 비치환된 퓨리닐기, 치환 또는 비치환된 퀴놀리닐기, 치환 또는 비치환된 이소퀴놀리닐기, 치환 또는 비치환된 프탈라지닐기, 치환 또는 비치환된 나프피리디닐기, 치환 또는 비치환된 퀴녹살리닐기, 치환 또는 비치환된 퀴나졸리닐기, 치환 또는 비치환된 아크리디닐기, 또는 치환 또는 비치환된 페난트롤리닐기, 바람직하게는 치환 또는 비치환된 피리디닐기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 싸이오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 벤조싸이오페닐기, 치환 또는 비치환된 인돌릴기, 치환 또는 비치환된 이미다조[1,2-a]피리디닐기, 치환 또는 비치환된 벤지이미다졸릴기, 치환 또는 비치환된 인다졸릴기, 치환 또는 비치환된 페노티아지닐기, 치환 또는 비치환된 페나지닐기, 치환 또는 비치환된 카바졸릴기, 또는 치환 또는 비치환된 디벤조싸이오페닐기일 수 있다.Examples of the substituted or unsubstituted C2 to C30 heteroaryl group include a substituted or unsubstituted pyridinyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted thiazinyl group, a substituted or unsubstituted thiophenyl group , A substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted benzothiophenyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted imidazo [1,2-a] pyridinyl group, a substituted or unsubstituted A substituted or unsubstituted indazolyl group, a substituted or unsubstituted phenothiazinyl group, a substituted or unsubstituted phenazinyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzoyl group, Substituted or unsubstituted imidazolyl groups, substituted or unsubstituted thiazolyl groups, substituted or unsubstituted tetrazolyl groups, substituted or unsubstituted oxadiazolyl groups, substituted or unsubstituted oxatriazolyl groups, However, A substituted or unsubstituted thiazolyl group, a substituted or unsubstituted benzothiazolyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted pyridazinyl group, a substituted or unsubstituted furyl group, a substituted or unsubstituted thiazolyl group, A substituted or unsubstituted quinoxalinyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted quinoxalinyl group, a substituted or unsubstituted phthalazinyl group, a substituted or unsubstituted naphthyridinyl group, Or a substituted or unsubstituted phenanthrolinyl group, preferably a substituted or unsubstituted pyridinyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted aryidinyl group, a substituted or unsubstituted pyrazolinyl group, A substituted or unsubstituted thiazolyl group, a substituted or unsubstituted thiophenyl group, a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted benzothiophenyl group, a substituted or unsubstituted indolyl group, A substituted or unsubstituted benzothiazolyl group, a substituted or unsubstituted phenothiazyl group, a substituted or unsubstituted phenazinyl group, a substituted or unsubstituted benzothiazolyl group, , A substituted or unsubstituted carbazolyl group, or a substituted or unsubstituted dibenzothiophenyl group.

상기 유기전계발광소자용 화합물은 하기 구조식으로 표시되는 화합물 1 내지 92 중에서 선택된 어느 하나인 것을 특징으로 하는 유기전계발광소자용 화합물일 수 있다.The organic electroluminescent device compound may be any one selected from compounds 1 to 92 represented by the following structural formulas.

Figure 112012107028500-pat00044
Figure 112012107028500-pat00044

Figure 112012107028500-pat00045
Figure 112012107028500-pat00045

Figure 112012107028500-pat00046
Figure 112012107028500-pat00046

Figure 112012107028500-pat00047
Figure 112012107028500-pat00047

Figure 112012107028500-pat00048
Figure 112012107028500-pat00048

Figure 112012107028500-pat00049
Figure 112012107028500-pat00049

Figure 112012107028500-pat00050
Figure 112012107028500-pat00050

Figure 112012107028500-pat00051
Figure 112012107028500-pat00051

Figure 112012107028500-pat00052
Figure 112012107028500-pat00052

Figure 112012107028500-pat00053
Figure 112012107028500-pat00053

Figure 112012107028500-pat00054
Figure 112012107028500-pat00054

본 발명의 다른 측면에 따르면, 상기 유기전계발광소자용 화합물을 포함하는 유기전계발광소자가 제공될 수 있다.According to another aspect of the present invention, there is provided an organic electroluminescent device comprising the compound for an organic electroluminescent device.

본 발명의 또 다른 측면에 따르면, 제1전극, 제2전극 및 제1전극과 제2전극 사이에 단수 또는 복수의 유기물층을 포함하는 유기전계발광소자에 있어서, 상기 단수 또는 복수의 유기물층 중에서 선택된 1종 이상의 유기물층은 상기 유기전계발광소자용 화합물을 포함할 수 있다.According to another aspect of the present invention, there is provided an organic electroluminescent device comprising a first electrode, a second electrode, and a single or a plurality of organic layers between a first electrode and a second electrode, The organic or more organic compound layer may include the compound for an organic electroluminescence device.

상기 단수 또는 복수의 유기물층은 발광층을 포함할 수 있다.The singular or plural organic layers may include a light emitting layer.

상기 복수의 유기물층은 발광층을 포함하고, 상기 복수의 유기물층은 전자주입층, 전자수송층, 정공차단층, 전자차단층, 정공수송층 및 정공주입층 중에서 선택된 1종 이상을 추가로 포함할 수 있다.The plurality of organic layers may include a light emitting layer, and the plurality of organic layers may further include at least one selected from an electron injecting layer, an electron transporting layer, a hole blocking layer, an electron blocking layer, a hole transporting layer, and a hole injecting layer.

상기 발광층은 호스트와 도펀트를 포함할 수 있다. The light emitting layer may include a host and a dopant.

본 발명은 전기적 안정성 및 전자와 홀 수송능력이 우수하며, 삼중항 상태 에너지가 높아 인광발광재료의 발광효율을 향상 시킬 수 있는 호스트, 정공주입물질, 정공수송물질, 전자수송물질, 전자주입물질 및 탑 이미션(top emission) 방식에서 굴절률이 우수한 밀봉 물질로 사용할 수 있는 유기발광소자용 화합물 및 이를 포함하는 유기전계발광소자를 제공할 수 있다.The present invention relates to a host, a hole injecting material, a hole transporting material, an electron transporting material, an electron injecting material, and a hole injecting material which are excellent in electrical stability and electron and hole transporting ability and have high triplet state energy, A compound for an organic light emitting device which can be used as a sealing material having an excellent refractive index in a top emission method and an organic electroluminescent device including the same can be provided.

도 1은 본 발명의 일 실시예에 따른 유기전계발광소자의 단면을 나타낸 단면도이다.
도 2는 본 발명의 다른 일 실시예에 따른 유기전계발광소자의 단면을 나타낸 단면도이다.
1 is a cross-sectional view illustrating an organic electroluminescent device according to an embodiment of the present invention.
2 is a cross-sectional view illustrating an organic electroluminescent device according to another embodiment of the present invention.

본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있는 바, 특정 실시예들을 예시하고 상세한 설명에 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.The invention is capable of various modifications and may have various embodiments, and particular embodiments are exemplified and will be described in detail in the detailed description. It is to be understood, however, that the invention is not to be limited to the specific embodiments, but includes all modifications, equivalents, and alternatives falling within the spirit and scope of the invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.

또한, 이하에서 사용될 제1, 제2 등과 같이 서수를 포함하는 용어는 다양한 구성요소들을 설명하는데 사용될 수 있지만, 상기 구성요소들은 상기 용어들에 의해 한정되지는 않는다. 상기 용어들은 하나의 구성요소를 다른 구성요소로부터 구별하는 목적으로만 사용된다. 예를 들어, 본 발명의 권리 범위를 벗어나지 않으면서 제1 구성요소는 제2 구성요소로 명명될 수 있고, 유사하게 제2 구성요소도 제1 구성요소로 명명될 수 있다. Furthermore, terms including an ordinal number such as the first, second, etc. to be used below can be used to describe various elements, but the constituent elements are not limited by the terms. The terms are used only for the purpose of distinguishing one component from another. For example, without departing from the scope of the present invention, the first component may be referred to as a second component, and similarly, the second component may also be referred to as a first component.

또한, 어떤 구성요소가 다른 구성요소 상에 "형성되어" 있다거나 "적층되어" 있다고 언급된 때에는, 그 다른 구성요소의 표면 상의 전면 또는 일면에 직접 부착되어 형성되어 있거나 적층되어 있을 수도 있지만, 중간에 다른 구성요소가 더 존재할 수도 있다고 이해되어야 할 것이다.Also, when an element is referred to as being "formed" or "laminated" on another element, it may be directly attached or laminated to the front surface or one surface of the other element, It will be appreciated that other components may be present in the < / RTI >

단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 출원에서, "포함하다" 또는 "가지다" 등의 용어는 명세서상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.The singular expressions include plural expressions unless the context clearly dictates otherwise. In the present application, the terms "comprises" or "having" and the like are used to specify that there is a feature, a number, a step, an operation, an element, a component or a combination thereof described in the specification, But do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, or combinations thereof.

본 명세서에서 "원자가결합"이란 별도의 정의가 없는 한, 단일결합, 이중결합 또는 삼중결합을 의미한다.As used herein, "atomic bond" means a single bond, a double bond or a triple bond, unless otherwise defined.

본 명세서에서 "치환"이란 별도의 정의가 없는 한, 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, 할로겐기, 히드록시기, 아미노기, C1 내지 C30 아민기, 니트로기, C1 내지 C30 실릴기, C1 내지 C30 알킬기, C1 내지 C30 알킬실릴기, C3 내지 C30 시클로알킬기, C1 내지 C30 헤테로시클로알킬기, C6 내지 C30 아릴기, C1 내지 C30 헤테로 아릴기, C1 내지 C20 알콕시기, C1 내지 C10 트리플루오로알킬기 또는 시아노기로 치환된 것을 의미한다.As used herein, unless otherwise defined, "substituent" means that at least one hydrogen in the substituent or compound is substituted with one or more substituents selected from the group consisting of deuterium, a halogen group, a hydroxy group, an amino group, a C1 to C30 amine group, a nitro group, a C1 to C30 silyl group, An alkyl group, a C1 to C30 alkylsilyl group, a C3 to C30 cycloalkyl group, a C1 to C30 heterocycloalkyl group, a C6 to C30 aryl group, a C1 to C30 heteroaryl group, a C1 to C20 alkoxy group, a C1 to C10 trifluoroalkyl group, It means that it has been replaced by anger.

또한 상기 치환된 할로겐기, 히드록시기, 아미노기, C1 내지 C30 아민기, C3 내지 C30 실릴기, C1 내지 C30 알킬기, C1 내지 C30 알킬실릴기, C3 내지 C30 시클로알킬기, C6 내지 C30 아릴기, C1 내지 C20 알콕시기, C1 내지 C10 트리플루오로알킬기 또는 시아노기 중 인접한 두 개의 치환기가 융합되어 고리를 형성할 수도 있다.A C1 to C30 alkyl group, a C1 to C30 alkylsilyl group, a C3 to C30 cycloalkyl group, a C6 to C30 aryl group, a C1 to C20 aryl group, a C1 to C30 aryl group, a C1 to C30 aryl group, An alkoxy group, a C1 to C10 trifluoroalkyl group or a cyano group may be fused to form a ring.

본 명세서에서 "헤테로"란 별도의 정의가 없는 한, 하나의 작용기 내에 N, O, S 및 P로 이루어진 군에서 선택되는 헤테로 원자를 1 내지 4개 함유하고, 나머지는 탄소인 것을 의미한다.As used herein, unless otherwise defined, it is meant that one functional group contains 1 to 4 heteroatoms selected from the group consisting of N, O, S, and P, and the remainder is carbon.

본 명세서에서 "이들의 조합"이란 별도의 정의가 없는 한, 둘 이상의 치환기가 연결기로 결합되어 있거나, 둘 이상의 치환기가 축합하여 결합되어 있는 것을 의미한다.In the present specification, the term "combination thereof" means that two or more substituents are bonded to each other via a linking group or two or more substituents are condensed and bonded.

본 명세서에서 "수소"란 별도의 정의가 없는 한, 일중수소, 이중수소, 또는 삼중수소를 의미한다. As used herein, "hydrogen" means monohydrogen, double hydrogen, or tritium, unless otherwise defined.

본 명세서에서 "알킬(alkyl)기"란 별도의 정의가 없는 한, 지방족 탄화수소기를 의미한다. As used herein, unless otherwise defined, the term "alkyl group" means an aliphatic hydrocarbon group.

알킬기는 어떠한 이중결합이나 삼중결합을 포함하고 있지 않은 "포화 알킬(saturated alkyl)기" 일 수 있다. The alkyl group may be a "saturated alkyl group" which does not contain any double or triple bonds.

알킬기는 적어도 하나의 이중결합 또는 삼중결합을 포함하고 있는 "불포화 알킬(unsaturated alkyl)기"일 수도 있다. The alkyl group may be an "unsaturated alkyl group" comprising at least one double bond or triple bond.

"알케닐렌(alkenylene)기"는 적어도 두 개의 탄소원자가 적어도 하나의 탄소-탄소 이중 결합으로 이루어진 작용기를 의미하며, "알키닐렌(alkynylene)기" 는 적어도 두 개의 탄소원자가 적어도 하나의 탄소-탄소 삼중 결합으로 이루어진 작용기를 의미한다. 포화이든 불포화이든 간에 알킬기는 분지형, 직쇄형 또는 환형일 수 있다. "Alkynylene group" means a functional group in which at least two carbon atoms are composed of at least one carbon-carbon double bond, and "alkynylene group" means that at least two carbon atoms have at least one carbon- Quot; means a functional group formed by bonding. The alkyl group, whether saturated or unsaturated, can be branched, straight chain or cyclic.

알킬기는 C1 내지 C30 알킬기일 수 있다. 보다 구체적으로 알킬기는 C1 내지 C20 알킬기, C1 내지 C10 알킬기 또는 C1 내지 C6 알킬기일 수도 있다.The alkyl group may be a C1 to C30 alkyl group. More specifically, the alkyl group may be a C1 to C20 alkyl group, a C1 to C10 alkyl group or a C1 to C6 alkyl group.

예를 들어, C1 내지 C4 알킬기는 알킬쇄에 1 내지 4 개의 탄소원자, 즉, 알킬쇄는 메틸, 에틸, 프로필, 이소-프로필, n-부틸, 이소-부틸, sec-부틸 및 t-부틸로 이루어진 군에서 선택됨을 나타낸다.For example, the C1 to C4 alkyl groups may have 1 to 4 carbon atoms in the alkyl chain, i.e., the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of methyl, ethyl, propyl, iso-propyl, n-butyl, Indicating that they are selected from the group.

구체적인 예를 들어 상기 알킬기는 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, t-부틸기, 펜틸기, 헥실기, 에테닐기, 프로페닐기, 부테닐기, 시클로프로필기, 시클로부틸기, 시클로펜틸기, 시클로헥실기 등을 의미한다.Specific examples of the alkyl group include a methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, t-butyl group, pentyl group, hexyl group, ethenyl group, Butyl group, cyclopentyl group, cyclohexyl group, and the like.

"아민기"는 아릴아민기, 알킬아민기, 아릴알킬아민기, 또는 알킬아릴아민기를 포함한다.The "amine group" includes an arylamine group, an alkylamine group, an arylalkylamine group, or an alkylarylamine group.

"시클로알킬(cycloalkyl)기"는 모노시클릭 또는 융합고리 폴리시클릭(즉, 탄소원자들의 인접한 쌍들을 나눠 가지는 고리) 작용기를 포함한다."Cycloalkyl group" includes monocyclic or fused-ring polycyclic (i. E., Rings that divide adjacent pairs of carbon atoms) functional groups.

"헤테로시클로알킬(heterocycloalkyl)기"는 시클로알킬기 내에 N, O, S 및 P로 이루어진 군에서 선택되는 헤테로원자를 1 내지 4개 함유하고, 나머지는 탄소인 것을 의미한다. 상기 헤테로시클로알킬기가 융합고리인 경우, 각각의 고리마다 상기 헤테로 원자를 1 내지 4개 포함할 수 있다."Heterocycloalkyl group" means that the cycloalkyl group contains 1 to 4 hetero atoms selected from the group consisting of N, O, S and P in the cycloalkyl group, and the remainder is carbon. When the heterocycloalkyl group is a fused ring, it may contain 1 to 4 heteroatoms in each ring.

"방향족(aromatic)기"는 고리 형태인 작용기의 모든 원소가 p-오비탈을 가지고 있으며, 이들 p-오비탈이 공액(conjugation)을 형성하고 있는 작용기를 의미한다. 구체적인 예로 아릴기와 헤테로아릴기가 있다. "An aromatic group" means a functional group in which all elements of a functional group in the form of a ring have a p-orbital, and these p-orbital forms a conjugation. Specific examples thereof include an aryl group and a heteroaryl group.

"아릴(aryl)기"는 모노시클릭 또는 융합 고리 폴리시클릭(즉, 탄소원자들의 인접한 쌍들을 나눠 가지는 고리) 작용기를 포함한다. An "aryl group" includes a monocyclic or fused ring polycyclic (i. E., A ring that divides adjacent pairs of carbon atoms) functional groups.

"헤테로아릴(heteroaryl)기"는 아릴기 내에 N, O, S 및 P로 이루어진 군에서 선택되는 헤테로원자를 1 내지 4개 함유하고, 나머지는 탄소인 것을 의미한다. 상기 헤테로아릴기가 융합고리인 경우, 각각의 고리마다 상기 헤테로 원자를 1 내지 4개 포함할 수 있다. "Heteroaryl group" means that the aryl group contains 1 to 4 hetero atoms selected from the group consisting of N, O, S and P, and the remainder is carbon. When the heteroaryl group is a fused ring, it may contain 1 to 4 heteroatoms in each ring.

아릴기 및 헤테로아릴기에서 고리의 원자수는 탄소수 및 비탄소원자수의 합이다.In the aryl group and the heteroaryl group, the number of atoms in the ring is the sum of carbon number and non-carbon atom number.

"알킬아릴기" 또는 "아릴알킬기"와 같이 조합하여 사용할 때, 상기에 든 각각의 알킬 및 아릴의 용어는 상기 나타낸 의미와 내용을 가진다.When used in combination, such as "alkylaryl" or "arylalkyl group ", the terms alkyl and aryl of each of the above have the meanings and contents indicated above.

"아릴알킬기"이란 용어는 벤질과 같은 아릴 치환된 알킬 라디칼을 의미하며 알킬기에 포함된다.The term "arylalkyl group " means an aryl substituted alkyl radical, such as benzyl, and is included in the alkyl group.

"알킬아릴기"이란 용어는 알킬 치환된 아릴 라디칼을 의미하며 아릴기에 포함된다.The term "alkylaryl group " means an alkyl substituted aryl radical and is included in the aryl group.

이하, 본 발명의 실시예를 첨부도면을 참조하여 설명하기로 하며, 첨부 도면을 참조하여 설명함에 있어, 동일하거나 대응하는 구성 요소는 동일한 도면번호를 부여하고 이에 대한 중복되는 설명은 생략하기로 한다.DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings. Referring to the accompanying drawings, the same or corresponding components are denoted by the same reference numerals, .

도 1 및 2를 참고하면, 본 발명의 실시예에 따르면 본 발명에 따른 유기전계발광소자용 화합물을 포함하는 유기전계발광소자(1)가 제공될 수 있다.Referring to FIGS. 1 and 2, an organic electroluminescent device 1 including the compound for an organic electroluminescent device according to the present invention can be provided according to an embodiment of the present invention.

본 발명의 다른 실시예에 따르면, 상기 유기전계발광소자는 제1전극(110); 제2전극(150); 및 상기 제1전극과 제2전극 사이에 단수 또는 복수의 유기물층(130)을 포함하며, 상기 단수 또는 복수의 유기물층(130) 중에서 선택된 1종 이상의 유기물층은 본 발명에 따른 유기발광소자용 화합물을 포함할 수 있다.According to another embodiment of the present invention, the organic electroluminescent device includes a first electrode 110; A second electrode (150); And one or more organic layers 130 between the first and second electrodes and at least one organic layer selected from the single or plurality of organic layers 130 include the compound for an organic light emitting device according to the present invention can do.

여기서, 상기 단수 또는 복수의 유기물층(130)은 발광층(134)을 포함할 수 있다. Here, the single or plural organic layers 130 may include a light emitting layer 134.

또한 상기 복수의 유기물층(130)은 발광층(134)을 포함하고, 상기 복수의 유기물층은 전자주입층(131), 전자수송층(132), 정공차단층(133), 전자차단층(135), 정공수송층(136) 및 정공주입층(137) 중에서 선택된 1종 이상을 추가로 포함할 수 있다.The plurality of organic layers 130 may include a light emitting layer 134 and the plurality of organic layers may include an electron injection layer 131, an electron transport layer 132, a hole blocking layer 133, an electron blocking layer 135, Transporting layer 136 and hole-injecting layer 137 may be further included.

상기 발광층(134)은 호스트와 도펀트를 포함할 수 있다.The light emitting layer 134 may include a host and a dopant.

상기 유기전계발광소자는 바람직하게는 투명기판에 의하여 지지된다. 투명기판의 재료로는 양호한 기계적 강도, 열안정성 및 투명성을 갖는 한 특별한 제한은 없다. 구체적인 예를 들면, 유리, 투명 플라스틱 필름 등을 사용할 수 있다.The organic electroluminescent device is preferably supported by a transparent substrate. The material of the transparent substrate is not particularly limited as long as it has good mechanical strength, thermal stability and transparency. Specific examples thereof include glass, transparent plastic film, and the like.

본 발명의 유기전계발광소자의 양극재료로서는 4eV 이상의 일함수를 갖는 금속, 합금, 전기전도성 화합물 또는 이의 혼합물을 사용할 수 있다. 구체적으로는 금속인 Au 또는 CuI, ITO(인듐 주석 산화물), SnO2 및 ZnO와 같은 투명 전도성 재료를 들 수 있다. 양극 필름의 두께는 10 내지 200nm 가 바람직하다.As the cathode material of the organic electroluminescent device of the present invention, a metal, an alloy, an electroconductive compound or a mixture thereof having a work function of 4 eV or more can be used. Specifically, transparent conductive materials such as Au or CuI, ITO (indium tin oxide), SnO 2 and ZnO, which are metals, can be mentioned. The thickness of the positive electrode film is preferably 10 to 200 nm.

본 발명의 유기전계발광소자의 음극 재료로서는 4eV 미만의 일함수를 갖는 금속, 합금, 전기 전도성 화합물 또는 이의 혼합물을 사용할 수 있다. 구체적으로는, Na, Na-K 합금, 칼슘, 마그네슘, 리튬, 리튬 합금, 인듐, 알루미늄, 마그네슘 합금, 알루미늄 합금을 들 수 있다. 이외에, 알루미늄/AlO2, 알루미늄/리튬, 마그네슘/은 또는 마그네슘/인듐 등도 사용될 수 있다. 음극필름의 두께는 10 내지 200nm 가 바람직하다.As the anode material of the organic electroluminescent device of the present invention, a metal, an alloy, an electrically conductive compound or a mixture thereof having a work function of less than 4 eV may be used. Specifically, Na, Na-K alloy, calcium, magnesium, lithium, lithium alloy, indium, aluminum, magnesium alloy and aluminum alloy can be mentioned. In addition, aluminum / AlO 2 , aluminum / lithium, magnesium / silver or magnesium / indium may be used. The thickness of the negative electrode film is preferably 10 to 200 nm.

유기 EL 소자의 발광효율을 높이기 위해서는 하나 이상의 전극은 바람직하게는 10% 이상의 광투과율을 가지는 것이 바람직하다. 전극의 쉬트저항은 바람직하게는 수백 Ω/mm 이하이다. 전극의 두께는 10nm 내지 1㎛, 보다 바람직하게는 10 내지 400nm 이다. 이러한 전극은 화학적 기상증착(CVD), 물리적 기상증착(PVD) 등의 기상증착법 또는 스퍼터링법을 통하여 상기한 전극 재료를 박막으로 형성하여 제조할 수 있다.In order to increase the luminous efficiency of the organic EL device, at least one electrode preferably has a light transmittance of 10% or more. The sheet resistance of the electrode is preferably several hundreds? / Mm or less. The thickness of the electrode is 10 nm to 1 탆, more preferably 10 to 400 nm. Such an electrode can be manufactured by forming the electrode material into a thin film by a vapor deposition method such as chemical vapor deposition (CVD) or physical vapor deposition (PVD) or a sputtering method.

또한 본 발명의 목적에 적합하게 본 발명의 유기전계발광소자용 화합물이 사용될 때, 공지된 정공수송 물질, 정공주입 물질, 발광층 물질, 발광층의 호스트 물질, 전자수송 물질, 및 전자주입 물질이 상기 각각의 유기물층에서 단독으로 사용되거나 또는 본 발명의 유기전계발광소자용 화합물과 선택적으로 병행하여 사용될 수 있다.When the compound for an organic electroluminescence device of the present invention is used for the purpose of the present invention, the known hole transporting material, hole injecting material, light emitting layer material, host material of the light emitting layer, electron transporting material, Or may be used in combination with the organic electroluminescent device compound of the present invention selectively.

정공 수송 물질로서 N,N-dicarbazolyl-3,5-benzene(mCP), poly(3,4-ethylenedioxythiophene):polystyrenesulfonate (PEDOT:PSS), N, N’-di(1-naphthyl)-N,N’-diphenylbenzidine(NPD), N,N'-디페닐-N,N'-디(3-메틸페닐)-4,4'-디아미노비페닐(TPD), N,N'-디페닐-N,N'-디나프틸-4,4'-디아미노비페닐, N,N,N'N'-테트라-p-톨릴-4,4'-디아미노비페닐, N,N,N'N'-테트라페닐-4,4'-디아미노비페닐, 코퍼(II)1,10,15,20-테트라페닐-21H,23H-포피린 등과 같은 포피린(porphyrin)화합물 유도체, 주쇄 또는 측쇄내에 방향족 3차아민을 갖는 중합체, 1,1-비스(4-디-p-톨릴아미노페닐)시클로헥산, N,N,N-트리(p-톨릴)아민, 4, 4', 4'-트리스[N-(3-메틸페닐)-N-페닐아미노]트리페닐아민과 같은 트리아릴아민 유도체, N-페닐카르바졸 및 폴리비닐카르바졸과 같은 카르바졸 유도체, 무금속 프탈로시아닌, 구리프탈로시아닌과 같은 프탈로시아닌 유도체, 스타버스트 아민 유도체, 엔아민스틸벤계 유도체, 방향족 삼급아민과 스티릴 아민 화합물의 유도체, 및 폴리실란 등을 들 수 있다.N-dicarbazolyl-3,5-benzene (mCP), poly (3,4-ethylenedioxythiophene): polystyrenesulfonate (PEDOT: PSS), N, N'- (NPD), N, N'-diphenyl-N, N'-di (3-methylphenyl) -4,4'- diaminobiphenyl (TPD) N, N'N'-tetra-p-tolyl-4,4'-diaminobiphenyl, N, N'N'N'N'- Porphyrin compound derivatives such as tetraphenyl-4,4'-diaminobiphenyl, copper (II) 1,10,15,20-tetraphenyl-21H, 23H-porphyrin and the like, aromatic tertiary (4-di-p-tolylaminophenyl) cyclohexane, N, N, N-tri (3-methylphenyl) -N-phenylamino] triphenylamine, carbazole derivatives such as N-phenylcarbazole and polyvinylcarbazole, phthalocyanine derivatives such as nonmetal phthalocyanine and copper phthalocyanine, An aminostilbene derivative, a derivative of an aromatic tertiary amine and a styrylamine compound, and polysilane.

전자 수송 물질로서 diphenylphosphine oxide-4-(triphenylsilyl)phenyl (TSPO1), Alq3, 2,5-디아릴 실롤 유도체(PyPySPyPy), 퍼플루오리네이티드 화합물(PF-6P), Octasubstituted cyclooctatetraene 화합물(COTs)을 들 수 있다.The diphenylphosphine oxide-4- (triphenylsilyl) phenyl (TSPO1), Alq 3, 2,5- diaryl silole derivatives (PyPySPyPy), perfluoro rineyi suited compound (PF-6P), Octasubstituted cyclooctatetraene compound (COTs) as an electron transport material .

본 발명의 유기전계발광소자에 있어서, 전자 주입층, 전자 수송층, 정공 수송층 및 정공 주입층은 상기한 화합물의 하나 이상의 종류를 함유하는 단일 층으로 형성되거나, 또는 상호 적층된, 상이한 종류의 화합물을 함유하는 복수의 층으로 구성될 수 있다.In the organic electroluminescent device of the present invention, the electron injecting layer, the electron transporting layer, the hole transporting layer, and the hole injecting layer may be formed of a single layer containing at least one kind of the above-mentioned compounds, And the like.

발광재료로서 예를 들면 축광 형광재료, 형광증백제, 레이저 색소, 유기 신틸레이터 및 형광 분석용 시약을 들 수 있다. 구체적으로는, 카바졸계 화합물, 포스핀옥사이드계 화합물, 카바졸계 포스핀옥사이드 화합물, bis((3,5-difluoro-4-cyanophenyl)pyridine) iridium picolinate(FCNIrpic), tris(8-hydroxyquinoline) aluminum(Alq3), 안트라센, 페난트렌, 피렌, 크리센, 페릴렌, 코로넨, 루브렌 및 퀴나크리돈과 같은 폴리아로마틱 화합물, 퀴터페닐과 같은 올리고페닐렌 화합물, 1,4-비스 (2-메틸스티릴)벤젠, 1,4-비스(4-메틸스티릴)벤젠, 1,4-비스(4-메틸-5-페닐-2-옥사졸릴)벤젠, 1,4-비스(5-페닐-2-옥사졸릴)벤젠, 2,5-비스(5-t-부틸-2-벤즈옥사졸릴)사이오펜, 1,4-디페닐-1,3-부타디엔, 1,6-디페닐-1,3,5-헥사트리엔,1,1,4,4-테트라페닐-1,3-부타디엔과 같은 액체신틸레이션용 신틸레이터, 옥신 유도체의 금속착체, 쿠마린 색소, 디시아노메틸렌피란 색소, 디시아노메틸렌사이오피란 색소, 폴리메틴 색소, 옥소벤즈안트라센 색소, 크산텐 색소, 카르보스티릴 색소, 페릴렌 색소, 옥사진 화합물, 스틸벤 유도체, 스피로 화합물, 옥사디아졸 화합물 등을 들 수 있다.Examples of the light emitting material include a phosphorescent fluorescent material, a fluorescent whitening agent, a laser dye, an organic scintillator, and a reagent for fluorescence analysis. Specifically, a carbazole compound, a phosphine oxide compound, a carbazole-based phosphine oxide compound, bis (3,5-difluoro-4-cyanophenyl) pyridine, iridium picolinate (FCNIrpic), tris (8-hydroxyquinoline) aluminum Alq 3 ), polyaromatic compounds such as anthracene, phenanthrene, pyrene, chrysene, perylene, coronene, rubrene and quinacridone, oligophenylene compounds such as quaterphenyl, 1,4- Bis (4-methylstyryl) benzene, 1,4-bis (4-methyl- Bis (5-t-butyl-2-benzoxazolyl) thiophene, 1,4-diphenyl-1,3-butadiene, 1,6- Liquid scintillation scintillators such as 3,5-hexatriene and 1,1,4,4-tetraphenyl-1,3-butadiene, metal complexes of oxine derivatives, coumarin dyes, dicyanomethylenepyran dyes, dicyanomethylene Cyopyran pigment, polymethine pigment, oxobenzanthracene There may be mentioned a colorant, a xanthene colorant, a carbostyryl colorant, a perylene colorant, an oxazine compound, a stilbene derivative, a spiro compound, and an oxadiazole compound.

본 발명의 유기 EL 소자를 구성하는 각 층은 진공 증착, 스핀 코팅 또는 캐스팅과 같은 공지된 방법을 통하여 박막으로 형성시키거나, 각 층에서 사용되는 재료를 이용하여 제조할 수 있다. 이들 각층의 막두께에 대해서는 특별한 제한은 없으며, 재료의 특성에 따라 알맞게 선택할 수 있으나, 보통 2nm 내지 5,000nm의 범위에서 결정될 수 있다.Each layer constituting the organic EL device of the present invention can be formed into a thin film through a known method such as vacuum deposition, spin coating or casting, or can be manufactured using a material used in each layer. The thickness of each of these layers is not particularly limited and may be appropriately selected according to the characteristics of the material, but may be determined usually in the range of 2 nm to 5,000 nm.

본 발명의 따른 유기전계발광소자용 화합물은 진공 증착법에 의하여 형성될 수 있으므로, 박막 형성 공정이 간편하고, 핀홀(pin hole)이 거의 없는 균질한 박막으로 용이하게 얻을 수 있는 장점이 있다.
The compound for an organic electroluminescence device according to the present invention can be formed by a vacuum deposition method, so that it is advantageous that a thin film forming process is simple and a homogeneous thin film having almost no pinhole can be easily obtained.

[실시예][Example]

이하, 실시예를 통하여 본 발명에 따른 유기전계발광소자용 화합물 및 이를 포함하는 유기전계발광소자의 제조방법을 더욱 구체적으로 설명한다. 그러나 이는 예시를 위한 것으로서 이에 의하여 본 발명의 범위가 한정되는 것이 아니다.Hereinafter, the compound for an organic electroluminescent device according to the present invention and the method for manufacturing the organic electroluminescent device including the same will be described in more detail with reference to the following examples. However, this is for the purpose of illustration only and is not intended to limit the scope of the invention.

실시예Example 1: 화합물 1 합성 1: Synthesis of compound 1

(1) (One) 제조예Manufacturing example 1: 중간체 1-1 합성 1: Synthesis of intermediate 1-1

Figure 112012107028500-pat00055
Figure 112012107028500-pat00055

1,2-diiodobenzene(19.8g, 0.06mol, sigma aldrich), triisopropyl borate(16.9g, 0.09mol, sigma aldrich), 촉매 CuI(1.14 g, 0.006 mol,sigma aldrich), Sodium hydride(2.2 g, 0.09mol,sigma aldrich)에 THF 800ml를 넣고 25℃에서 12시간 동안 교반하여 반응시켰다. 반응 종료 후 증류수를 넣고 추출하여 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 1-1을 15.3 g(수율 77%) 수득하였다.(1.14 g, 0.006 mol, sigma aldrich), sodium hydride (2.2 g, 0.09 mol) were added to a mixture of 1,2-diiodobenzene (19.8 g, 0.06 mol, sigma aldrich), triisopropyl borate , Sigma aldrich), and the mixture was reacted at 25 ° C for 12 hours with stirring. After completion of the reaction, distilled water was added thereto, and the mixture was extracted and purified by column (n-hexane: methylene chloride) to obtain 15.3 g (yield 77%) of Intermediate 1-1.

LC/MS: m/z=331[(M+1)+]LC / MS: m / z = 331 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 1-2: 중간체 1-2 합성 1-2: Intermediate 1-2 Synthesis

Figure 112012107028500-pat00056
Figure 112012107028500-pat00056

중간체 1-1(15.3g, 0.046mol), 1-iodo-2-nitrobenzene(7.5g, 0.03mol, sigma aldrich), Pd(OAc)2 (0.34g, 0.0015mol, sigma aldrich), P(tBu)2Me(0.48g, 0.003mol, sigma aldrich), KOtBu (10.1 g, 0.09 mol,sigma aldrich)에 t-Butyl alcohol 600ml를 넣고 25℃에서 교반하여 반응시켰다. 반응 종료 후 증류수를 넣고 추출하여 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 1-2을 8.5g(수율 57%) 수득하였다.Pd (OAc) 2 (0.34 g, 0.0015 mol, sigma aldrich), P (tBu) 2 (0.13 g, 0.046 mol), 1-iodo-2- 2Me (0.48 g, 0.003 mol, Sigma aldrich), 600 ml of t-butyl alcohol was added to KOtBu (10.1 g, 0.09 mol, Sigma aldrich) and reacted at 25 ° C with stirring. After completion of the reaction, distilled water was added thereto, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.5 g (yield: 57%) of intermediate 1-2.

LC/MS: m/z=325[(M+1)+]LC / MS: m / z = 325 [(M + 1) < + &

(3) (3) 제조예Manufacturing example 1-3: 중간체 1-3 합성 1-3: Synthesis of intermediate 1-3

Figure 112012107028500-pat00057
Figure 112012107028500-pat00057

중간체 1-2(8.5g, 0.026 mol), triphenylphosphine(20.5g, 0.078mol, sigma aldrich에 o-dichlorobenzene 340ml를 넣고 180℃에서 환류시켜 반응시켰다. 반응 종료 후 냉각 하여 증류수를 넣고 추출하여 칼럼 정제(n-Hexane : methylene chloride)하여 중간체 1-3을 6.8 g(수율 89%) 수득하였다.Dichlorobenzene (340 ml) was added to the reaction mixture, and the mixture was refluxed at 180 ° C. After completion of the reaction, the reaction mixture was cooled, distilled water was added thereto, n-Hexane: methylene chloride) to obtain 6.8 g (yield 89%) of intermediate 1-3.

LC/MS: m/z=293[(M+1)+]LC / MS: m / z = 293 [(M + 1) < + &

(4) (4) 제조예Manufacturing example 1-4: 중간체 1-4 합성 1-4: Intermediate 1-4 Synthesis

Figure 112012107028500-pat00058
Figure 112012107028500-pat00058

중간체 1-3(6.8g, 0.023mol), bromobenzene(3.6g, 0.023mol, sigma aldrich), Pd2(dba)3(1.1g, 0.0012mol, sigma aldrich), P(t-Bu)3(0.28g, 0.0014mol,sigma aldrich), NatOBu(2.7g, 0.028mol,sigma aldrich)에 Toluene 280ml를 넣고 80℃에서 교반하여 반응시켰다. 반응 종료 후 냉각 하여 증류수를 넣고 추출하여 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 1-4를 6.4 g(수율 75%) 수득하였다.Pd (dba) 3 (1.1 g, 0.0012 mol, sigma aldrich), P (t-Bu) 3 (0.28 g, 0.023 mol), bromobenzene (3.6 g, 0.023 mol, sigma aldrich) , 0.0014 mol, sigma aldrich) and NatOBu (2.7 g, 0.028 mol, Sigma aldrich) were charged with 280 ml of toluene and reacted at 80 ° C with stirring. After completion of the reaction, the reaction mixture was cooled, distilled water was added thereto, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain Intermediate 1-4 (6.4 g, yield 75%).

LC/MS: m/z=368[(M+1)+]LC / MS: m / z = 368 [(M + 1) < + &

(5) (5) 제조예Manufacturing example 1-5: 중간체 1-5 합성 1-5: Intermediate 1-5 Synthesis

Figure 112012107028500-pat00059
Figure 112012107028500-pat00059

Dibenzothiophene(20g, 0.109mol, sigma aldrich), N-Iodosuccinimide(12.1g, 0.054mol, sigma aldrich)과 Solvent Chloroform/Acetone(3:1)을 800ml를 넣고 25℃에서 교반하여 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량만큼 첨가하여 추출 후 칼럼 정제(n-Hexane)하여 중간체 1-5를 9g (수율 27%)수득하였다. 800ml of Dibenzothiophene (20g, 0.109mol, Sigma aldrich), N-Iodosuccinimide (12.1g, 0.054mol, Sigma aldrich) and Solvent Chloroform / Acetone (3: 1) were added and reacted at 25 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane) to obtain 9 g (yield: 27%) of Intermediate 1-5.

LC/MS: m/z=310[(M+1)+]LC / MS: m / z = 310 [(M + 1) < + &

(6) (6) 제조예Manufacturing example 1-6: 중간체 1-6 합성 1-6: Intermediate 1-6 Synthesis

Figure 112012107028500-pat00060
Figure 112012107028500-pat00060

중간체 1-5(9g, 0.029mol), 1,4-diiodobenzene(9.6g, 0.029mol, sigma aldrich), 촉매 Copper(II) (0.52g, 0.0029mol, sigma aldrich), Potassium fluoride(1.7g, 0.029mol, sigma aldrich)에 DMSO 360ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 1-6을 7.1g(수율 63%) 수득하였다.0.029 mol, sigma aldrich), Catalyst Copper (II) (0.52 g, 0.0029 mol, sigma aldrich), Potassium fluoride (1.7 g, 0.029 mol) mol, Sigma aldrich), and the reaction was carried out at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 7.1 g (yield 63%) of Intermediate 1-6.

LC/MS: m/z=386[(M+1)+]LC / MS: m / z = 386 [(M + 1) < + &

(7) (7) 제조예Manufacturing example 1-7: 화합물 1 합성 1-7: Synthesis of compound 1

Figure 112012107028500-pat00061
Figure 112012107028500-pat00061

중간체 1-6(7.1g, 0.018mol), 중간체 1-4(6.4g, 0.018mol), 촉매 Copper(II) (0.33g, 0.0018mol), Potassium fluoride(1.1g, 0.018mol)에 DMSO 280ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane : methylene chloride)하여 화합물 1을 4.6g(수율 51%) 수득하였다. 280 ml of DMSO was added to Intermediate 1-6 (7.1 g, 0.018 mol), Intermediate 1-4 (6.4 g, 0.018 mol), Catalyst Copper (II) (0.33 g, 0.0018 mol) and Potassium fluoride (1.1 g, And reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 4.6 g (yield: 51%) of Compound 1.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.50/M, 7.45/M, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 7.59/D, 7.43/M, 7.79/D, 7.98/D, 7.52/M, 8.45/D, 8.41/D, 8.20/D) 2H(7.50/D) 3H(7.58/M) 4H(7.25/D ) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 7.59 / D, 7.43 / M, 7.79 / D D, 7,98 / D, 7.52 / M, 8.45 / D, 8.41 / D, 8.20 / D) 2H (7.50 / D)

LC/MS: m/z=502[(M+1)+] LC / MS: m / z = 502 [(M + 1) < + &

실시예Example 2: 화합물 2 합성 2: Synthesis of compound 2

(1) (One) 제조예Manufacturing example 2-1: 중간체 2-1 합성 2-1: Synthesis of Intermediate 2-1

Figure 112012107028500-pat00062
Figure 112012107028500-pat00062

1-phenyl-1H-benzo[d]imidazole(21.2g, 0.109mol, sigma aldrich), N-Iodosuccinimide(12.1g, 0.054mol)과 Solvent Chloroform/Acetone(3:1)을 800ml를 넣고 25℃에서 교반하여 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량만큼 첨가하여 추출 후 칼럼 정제(n-Hexane)하여 중간체 2-1을 9.3g (수율 27%)수득하였다. 800 ml of N-Iodosuccinimide (12.1 g, 0.054 mol) and Solvent Chloroform / Acetone (3: 1) were added and stirred at 25 ° C. Lt; / RTI > After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane) to obtain 9.3 g (yield: 27%) of intermediate 2-1.

LC/MS: m/z=320[(M+1)+] LC / MS: m / z = 320 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 2-2: 중간체 2-2 합성 2-2: Intermediate 2-2 Synthesis

Figure 112012107028500-pat00063
Figure 112012107028500-pat00063

중간체 2-1(9.3g, 0.029mol), 1,4-diiodobenzene(9.6g, 0.029mol), 촉매 Copper(II) (0.52g, 0.0029mol), Potassium fluoride(1.7g, 0.029mol)에 DMSO 370ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 2-2를 7.1 g(수율 62%) 수득하였다.370 ml of DMSO was added to Intermediate 2-1 (9.3 g, 0.029 mol), 1,4-diiodobenzene (9.6 g, 0.029 mol), Catalyst Copper (II) (0.52 g, 0.0029 mol) And the reaction was carried out at 130 ° C. After the reaction mixture was cooled, water was added in an amount corresponding to the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 7.1 g (yield 62%) of Intermediate 2-2.

LC/MS: m/z=396[(M+1)+] LC / MS: m / z = 396 [(M + 1) < + &

(3) (3) 제조예Manufacturing example 2-3: 화합물 2 합성 2-3 Synthesis of compound 2

Figure 112012107028500-pat00064
Figure 112012107028500-pat00064

중간체 2-2(7.1g, 0.018mol), 중간체 1-4(6.4g, 0.018 mol), 촉매 Copper(II) (0.33g, 0.0018mol), Potassium fluoride(1.1g, 0.018mol)에 DMSO 280ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane : methylene chloride)하여 화합물 2를 4.6g(수율 50%) 수득하였다. 280 ml of DMSO was added to Intermediate 2-2 (7.1 g, 0.018 mol), Intermediate 1-4 (6.4 g, 0.018 mol), Catalyst Copper (II) (0.33 g, 0.0018 mol) and Potassium fluoride (1.1 g, And reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 4.6 g of Compound 2 (yield: 50%).

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.50/M, 7.29/M, 8.12/D, 7.63/D, 7.90/D, 7.39/M, 8.10/D, 7.59/D, 8.56/D) 2H(7.45/M, 7.22/M, 7.25/D, 7.85/D) 4H(7.50/D, 7.58/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.29 / M, 8.12 / D, 7.63 / D, 7.90 / D, 7.39 / M, 8.10 / D, 7.59 / D, 8.56 / D ) 2H (7.45 / M, 7.22 / M, 7.25 / D, 7.85 / D)

LC/MS: m/z= 512[(M+1)+] LC / MS: m / z = 512 [(M + 1) < + &

실시예Example 3: 화합물 5 합성 3: Compound 5 Synthesis

(1) (One) 제조예Manufacturing example 3-1: 중간체 5-1 합성 3-1: Intermediate 5-1 Synthesis

Figure 112012107028500-pat00065
Figure 112012107028500-pat00065

triphenylene (24.9g, 0.109mol, sigma aldrich), N-Iodosuccinimide(12.1g, 0.054mol)과 Solvent Chloroform/Acetone(3:1)을 800ml를 넣고 25℃에서 교반하여 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane)하여 중간체 5-1을 10.3g (수율 24%) 수득하였다. 800 ml of triphenylene (24.9 g, 0.109 mol, Sigma aldrich), N-Iodosuccinimide (12.1 g, 0.054 mol) and Solvent Chloroform / Acetone (3: 1) were added and reacted at 25 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent and the mixture was extracted and subjected to column purification (n-hexane) to obtain 10.3 g (yield: 24%) of intermediate 5-1.

LC/MS: m/z= 354[(M+1)+] LC / MS: m / z = 354 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 3-2: 중간체 5-2 합성 3-2: Intermediate 5-2 Synthesis

Figure 112012107028500-pat00066
Figure 112012107028500-pat00066

중간체 5-1(10.3g, 0.029mol), 1,4-diiodobenzene(9.6g, 0.029mol), 촉매 Copper(II) (0.52g, 0.0029mol), Potassium fluoride(1.7g, 0.029mol)에 DMSO 370ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 5-2를 7.7 g(수율 62%) 수득하였다.(m/z=430)370 ml of DMSO was added to Intermediate 5-1 (10.3 g, 0.029 mol), 1,4-diiodobenzene (9.6 g, 0.029 mol), Catalyst Copper (II) (0.52 g, 0.0029 mol) and Potassium fluoride (1.7 g, 0.029 mol) And the reaction was carried out at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 7.7 g (m / z = 430)

LC/MS: m/z= 430[(M+1)+] LC / MS: m / z = 430 [(M + 1) < + &

(3) (3) 제조예Manufacturing example 3-3: 화합물 5 합성 3-3: Compound 5 Synthesis

Figure 112012107028500-pat00067
Figure 112012107028500-pat00067

중간체 5-2(7.7g, 0.018mol), 중간체 1-4(6.4g, 0.018mol), 촉매 Copper(II) (0.33g, 0.0018mol), Potassium fluoride(1.1g, 0.018mol)에 DMSO 280ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane : methylene chloride)하여 화합물 5를 4.6g(수율 47%) 수득하였다. 280 ml of DMSO was added to Intermediate 5-2 (7.7 g, 0.018 mol), Intermediate 1-4 (6.4 g, 0.018 mol), Catalyst Copper (II) (0.33 g, 0.0018 mol) and Potassium fluoride (1.1 g, And reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 4.6 g (yield: 47%) of Compound 5.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.50/M, 7.45/M, 7.63/D, 7.29/M, 7.90/D, 7.39/M, 8.34/D, 8.99/D) 2H (8.10/D, 8.93/D, 7.88/M, 7.82/M, 7.50/D, 7.58/M) 3H(8.12/D) 4H (7.25/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.63 / D, 7.29 / M, 7.90 / D, 7.39 / M, 8.34 / D, 8.99 / D) 2H (8.10 D, 8.93 / D, 7.88 / M, 7.82 / M, 7.50 / D, 7.58 /

LC/MS: m/z= 546[(M+1)+] LC / MS: m / z = 546 [(M + 1) < + &

실시예Example 4: 화합물 6 합성 4: Synthesis of Compound 6

(1) (One) 제조예Manufacturing example 4-1: 중간체 6-1 합성 4-1: Synthesis of Intermediate 6-1

Figure 112012107028500-pat00068
Figure 112012107028500-pat00068

N-phenyldibenzo[b,d]thiophene-4-amine (30g, 0.109mol, sigma aldrich), N-Iodosuccinimide(12.1g, 0.054mol)과 Solvent Chloroform/Acetone(3:1)을 800ml를 넣고 25℃에서 교반하여 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane)하여 중간체 6-1을 11.6 g (수율 24%)수득하였다. 800 ml of N-phenyldibenzo [b, d] thiophene-4-amine (30g, 0.109mol, Sigma aldrich) and N-Iodosuccinimide (12.1g, 0.054mol) and Solvent Chloroform / Acetone And reacted with stirring. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane) to obtain 11.6 g (yield: 24%) of intermediate 6-1.

LC/MS: m/z= 401[(M+1)+] LC / MS: m / z = 401 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 4-2: 중간체 6-2 합성 4-2: Intermediate 6-2 Synthesis

Figure 112012107028500-pat00069
Figure 112012107028500-pat00069

중간체 6-1(11.6g, 0.029mol), 1,4-diiodobenzene(9.6g, 0.029mol), 촉매 Copper(II) (0.52g, 0.0029mol), Potassium fluoride(1.7g, 0.02 mol)에 DMSO 370ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 6-2를 8.6g(수율 62%) 수득하였다.DMSO (370 ml) was added to Intermediate 6-1 (11.6 g, 0.029 mol), 1,4-diiodobenzene (9.6 g, 0.029 mol), Catalyst Copper (II) (0.52 g, 0.0029 mol) and Potassium fluoride And the reaction was carried out at 130 ° C. After the reaction mixture was cooled, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (62% yield) of Intermediate 6-2.

LC/MS: m/z= 477[(M+1)+] LC / MS: m / z = 477 [(M + 1) < + &

(3) (3) 제조예Manufacturing example 4-3: 화합물 6 합성 4-3: Synthesis of Compound 6

Figure 112012107028500-pat00070
Figure 112012107028500-pat00070

중간체 6-2(8.6g, 0.018 ol), 중간체 1-4(6.4g, 0.018mol), 촉매 Copper(II) (0.33g, 0.0018mol), Potassium fluoride(1.1g, 0.018 ol)에 DMSO 280ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane : methylene chloride)하여 화합물 6을 4.6g(수율 43%) 수득하였다. 280 ml of DMSO was added to Intermediate 6-2 (8.6 g, 0.018 ol), Intermediate 1-4 (6.4 g, 0.018 mol), Catalyst Copper (II) (0.33 g, 0.0018 mol), Potassium fluoride (1.1 g, And reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 4.6 g (yield: 43%) of Compound 6.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.45/M, 7.63/D, 7.29/M, 8.12/D, 7.90/D, 7.39/M, 8.10/D, 6.81/M, 6.86/D, 7.27/M, 7.81/D, 8.45/D, 7.52/M, 7.98/D) 2H (7.50/M, 7.50/D, 7.58/M, 7.54/D, 6.69/D, 7.20/M, 6.63/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.63 / D, 7.29 / M, 8.12 / D, 7.90 / D, 7.39 / M, 8.10 / D, 6.81 / M, 6.86 / D 7.50 / D, 7.58 / M, 7.54 / D, 6.69 / D, 7.20 / M, 6.63 / D )

LC/MS: m/z= 593[(M+1)+] LC / MS: m / z = 593 [(M + 1) < + &

실시예Example 5: 화합물 7 합성 5: Synthesis of Compound 7

(1) (One) 제조예Manufacturing example 5-1: 중간체 7-1 합성 5-1: Intermediate 7-1 Synthesis

Figure 112012107028500-pat00071
Figure 112012107028500-pat00071

benzo[f][1,9]phenanthroline (25.1g, 0.109mol, sigma aldrich), N-Iodosuccinimide(12.1g, 0.054mol)과 Solvent Chloroform/Acetone(3:1)을 800ml를 넣고 25℃에서 교반하여 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane)하여 중간체 7-1을 10.3g (수율 27%)수득하였다.800 ml of benzo [f] [1,9] phenanthroline (25.1 g, 0.109 mol, Sigma aldrich) and N-Iodosuccinimide (12.1 g, 0.054 mol) and Solvent Chloroform / Acetone Lt; / RTI > The reaction mixture was cooled, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane) to obtain 10.3 g (yield: 27%) of Intermediate 7-1.

LC/MS: m/z= 356[(M+1)+] LC / MS: m / z = 356 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 5-2: 중간체 7-2 합성 5-2: Intermediate 7-2 Synthesis

Figure 112012107028500-pat00072
Figure 112012107028500-pat00072

중간체 7-1(11.6g, 0.029mol), 1,4-diiodobenzene(9.6g, 0.029mol), 촉매 Copper(II)(0.52g, 0.0029mol), Potassium fluoride(1.7g, 0.029mol)에 DMSO 370ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 7-2를 8.6g(수율 69%) 수득하였다.370 ml of DMSO was added to Intermediate 7-1 (11.6 g, 0.029 mol), 1,4-diiodobenzene (9.6 g, 0.029 mol), Catalyst Copper (II) (0.52 g, 0.0029 mol) And the reaction was carried out at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 69%) of Intermediate 7-2.

LC/MS: m/z= 432[(M+1)+] LC / MS: m / z = 432 [(M + 1) < + &

(3) (3) 제조예Manufacturing example 5-3: 화합물 7 합성 5-3: Synthesis of Compound 7

Figure 112012107028500-pat00073
Figure 112012107028500-pat00073

중간체 7-2(8.6g, 0.020mol), 중간체 1-4(6.8g, 0.020mol), 촉매 Copper(II) (0.38g, 0.0020mol), Potassium fluoride(1.2g, 0.020mol)에 DMSO 300ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane : methylene chloride)하여 화합물 7을 4.6g(수율 42%) 수득하였다. DMSO (300 ml) was added to Intermediate 7-2 (8.6 g, 0.020 mol), Intermediate 1-4 (6.8 g, 0.020 mol), Catalyst Copper (II) (0.38 g, 0.0020 mol) and Potassium fluoride And reacted at 130 ° C. The reaction mixture was cooled, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 4.6 g (yield: 42%) of Compound 7.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.50/M, 7.45/M, 7.63/D, 7.29/M, 8.12/D, 7.90/D, 7.39/M, 8.10/D, 7.58/M, 8.83/D, 8.38/D, 8.34/S, 7.73/D, 8.06/D, 7.50/D, 8.45/D, 8.91/S) 2H(7.50/D, 7.58/M) 4H(7.25/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.63 / D, 7.29 / M, 8.12 / D, 7.90 / D, 7.39 / M, 8.10 / D, 7.58 / M D, 8.38 / D, 8.34 / S, 7.73 / D, 8.06 / D, 7.50 / D, 8.45 / D, 8.91 / S) 2H (7.50 / D, 7.58 /

LC/MS: m/z=548 [(M+1)+] LC / MS: m / z = 548 [(M + 1) < + &

실시예Example 6: 화합물 12 합성 6: Synthesis of compound 12

(1) (One) 제조예Manufacturing example 6-1: 중간체 12-1 합성 6-1: Synthesis of Intermediate 12-1

Figure 112012107028500-pat00074
Figure 112012107028500-pat00074

5-phenyl-5,7a-dihydro-4bH-pyrrolo[3,2-f][1,10]phenanthroline (32.4g, 0.109mol, sigma aldrich), N-Iodosuccinimide(12.1g, 0.054mol)과 Solvent Chloroform/Acetone(3:1)을 800ml를 넣고 25℃에서 교반하여 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane)하여 중간체 12-1을 10.3g (수율 22%)수득하였다.(32.1 g, 0.109 mol, Sigma aldrich), N-Iodosuccinimide (12.1 g, 0.054 mol) and Solvent Chloroform / Acetone (3: 1), and the mixture was reacted at 25 ° C with stirring. After cooling the reaction mixture, water was added by the amount of the reaction solvent and the mixture was extracted and subjected to column purification (n-hexane) to obtain 10.3 g (yield: 22%) of Intermediate 12-1.

LC/MS: m/z=423 [(M+1)+] LC / MS: m / z = 423 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 6-2: 중간체 12-2 합성 6-2: Intermediate 12-2 Synthesis

Figure 112012107028500-pat00075
Figure 112012107028500-pat00075

중간체 12-1(10.3g, 0.024mol), 1,4-diiodobenzene(7.9g, 0.024mol), 촉매 Copper(II)(0.43g, 0.0024mol), Potassium fluoride(1.4g, 0.024mol)에 DMSO 400ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 12-2를 8.6 g(수율 72%) 수득하였다.400ml DMSO was added to Intermediate 12-1 (10.3g, 0.024mol), 1,4-diiodobenzene (7.9g, 0.024mol), Catalyst Copper (II) (0.43g, 0.0024mol) and Potassium fluoride (1.4g, 0.024mol) And the reaction was carried out at 130 ° C. After the reaction mixture was cooled, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 72%) of Intermediate 12-2.

LC/MS: m/z=499 [(M+1)+] LC / MS: m / z = 499 [(M + 1) < + &

(3) (3) 제조예Manufacturing example 6-3: 화합물 12 합성 6-3: Compound 12 Synthesis

Figure 112012107028500-pat00076
Figure 112012107028500-pat00076

중간체 12-2(8.6g, 0.017mol), 중간체 1-4(6.8g, 0.017mol), 촉매 Copper(II) (0.33g, 0.0017mol), Potassium fluoride(1.1g, 0.017mol)에 DMSO 300ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane : methylene chloride)하여 화합물 12를 4.6g(수율 44%) 수득하였다.300 ml of DMSO was added to Intermediate 12-2 (8.6 g, 0.017 mol), Intermediate 1-4 (6.8 g, 0.017 mol), Catalyst Copper (II) (0.33 g, 0.0017 mol) and Potassium fluoride And reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 4.6 g (yield: 44%) of Compound 12.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.50/M, 7.45/M, 7.63/D, 7.29/M, 8.12/D, 7.90/D, 7.39/M, 8.10/D, 6.77/M, 5.07/S, 4.07/S, 4.32/S, 7.48/D, 8.51/D, 7.67/D, 6.94/M, 8.53/D, 6.81/M) 2H(7.50/D, 7.59/D, 7.44/D, 7.58/M, 6.60/D, 7.23/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.63 / D, 7.29 / M, 8.12 / D, 7.90 / D, 7.39 / M, 8.10 / D, 6.77 / M D, 7.59 / D, 7.44 / D, 7.07 / S, 4.07 / S, 4.32 / S, 7.48 / D, 8.51 / D, 7.67 / D, 6.94 / , 7.58 / M, 6.60 / D, 7.23 / M)

LC/MS: m/z= 615[(M+1)+] LC / MS: m / z = 615 [(M + 1) < + &

실시예Example 7: 화합물 14 합성 7: Compound 14 Synthesis

(1) (One) 제조예Manufacturing example 7-1: 중간체 14-1 합성 7-1: Synthesis of Intermediate 14-1

Figure 112012107028500-pat00077
Figure 112012107028500-pat00077

pyrido[2,3-f][1,7]phenanthroline(25.2g, 0.109mol, sigma aldrich), N-Iodosuccinimide(12.1g, 0.054mol)과 Solvent Chloroform/Acetone(3:1)을 800ml를 넣고 25℃에서 교반하여 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane)하여 중간체 14-1을 10.3g (수율 26%)수득하였다. 800 ml of pyrido [2,3-f] [1,7] phenanthroline (25.2g, 0.109mol, Sigma aldrich) and N-Iodosuccinimide (12.1g, 0.054mol) and Solvent Chloroform / Acetone RTI ID = 0.0 > C < / RTI > After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane) to obtain 10.3 g (yield: 26%) of intermediate 14-1.

LC/MS: m/z= 357[(M+1)+] LC / MS: m / z = 357 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 7-2: 중간체 14-2 합성 7-2: Intermediate 14-2 Synthesis

Figure 112012107028500-pat00078
Figure 112012107028500-pat00078

중간체 14-1(10.3g, 0.029mol), 1,4-diiodobenzene(9.4g, 0.029mol), 촉매 Copper(II)(0.33g, 0.0029mol), Potassium fluoride(1.7g, 0.029mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 14-2를 8.6 g(수율 68%) 수득하였다.400ml DMSO was added to Intermediate 14-1 (10.3g, 0.029mol), 1,4-diiodobenzene (9.4g, 0.029mol), Catalyst Copper (II) (0.33g, 0.0029mol) and Potassium fluoride (1.7g, 0.029mol) And the reaction was carried out at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 68%) of intermediate 14-2.

LC/MS: m/z= 499[(M+1)+] LC / MS: m / z = 499 [(M + 1) < + &

(3) (3) 제조예Manufacturing example 7-3: 화합물 14 합성 7-3: Compound 14 Synthesis

Figure 112012107028500-pat00079
Figure 112012107028500-pat00079

중간체 14-2(8.6g, 0.020mol), 중간체 1-4(8.0g, 0.020mol), 촉매 Copper(II) (0.38g, 0.0020mol), Potassium fluoride(1.2g, 0.020mol)에 DMSO 300ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane : methylene chloride)하여 화합물 14를 4.6g(수율 42%) 수득하였다. 300 ml of DMSO was added to Intermediate 14-2 (8.6 g, 0.020 mol), Intermediate 1-4 (8.0 g, 0.020 mol), Catalyst Copper (II) (0.38 g, 0.0020 mol) and Potassium fluoride (1.2 g, And reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 4.6 g (yield: 42%) of Compound 14.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.50/M, 7.45/M, 7.63/D, 7.29/M, 8.12/D, 7.90/D, 7.39/M, 8.10/D, 8.57/S, 8.22/S) 2H(8.38/D, 8.83/D, 7.50/D) 4H(7.25/D, 7.58/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.63 / D, 7.29 / M, 8.12 / D, 7.90 / D, 7.39 / M, 8.10 / D, 8.57 / S , 8.22 / S) 2H (8.38 / D, 8.83 / D, 7.50 / D)

LC/MS: m/z=549[(M+1)+] LC / MS: m / z = 549 [(M + 1) < + &

실시예Example 8: 화합물 15 합성 8: Compound 15 Synthesis

(1) (One) 제조예Manufacturing example 8-1: 중간체 15-1 합성 8-1: Synthesis of Intermediate 15-1

Figure 112012107028500-pat00080
Figure 112012107028500-pat00080

diphenylamine (18.4g, 0.109mol, sigma aldrich), N-Iodosuccinimide(12.1g, 0.054mol)과 Solvent Chloroform/Acetone(3:1)을 800ml를 넣고 25℃에서 교반하여 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량만큼 첨가하여 추출 후 칼럼 정제(n-Hexane)하여 중간체 15-1을 10.3g (수율 32%)수득하였다. 800 ml of diphenylamine (18.4 g, 0.109 mol, Sigma aldrich), N-Iodosuccinimide (12.1 g, 0.054 mol) and Solvent Chloroform / Acetone (3: 1) were added and reacted at 25 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane) to obtain 10.3 g (yield: 32%) of intermediate 15-1.

LC/MS: m/z=295[(M+1)+] LC / MS: m / z = 295 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 8-2: 중간체 15-2 합성 8-2: Intermediate 15-2 Synthesis

Figure 112012107028500-pat00081
Figure 112012107028500-pat00081

중간체 15-1(10.3g, 0.035mol), 1,4-diiodobenzene(11.3g, 0.035mol), 촉매 Copper(II)(0.40g, 0.0029mol), Potassium fluoride(2.05g, 0.029mol)에 DMSO 400ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 15-2를 8.6 g(수율 66%) 수득하였다.400ml DMSO was added to Intermediate 15-1 (10.3g, 0.035mol), 1,4-diiodobenzene (11.3g, 0.035mol), Catalyst Copper (II) (0.40g, 0.0029mol) and Potassium fluoride (2.05g, 0.029mol) And the reaction was carried out at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield 66%) of intermediate 15-2.

LC/MS: m/z=371[(M+1)+] LC / MS: m / z = 371 [(M + 1) < + &

(3) (3) 제조예Manufacturing example 8-3: 화합물 15 합성 8-3: Compound 15 Synthesis

Figure 112012107028500-pat00082
Figure 112012107028500-pat00082

중간체 15-2(8.6g, 0.023mol), 중간체 1-4(9.2g, 0.023mol), 촉매 Copper(II) (0.44g, 0.0020mol), Potassium fluoride(1.4g, 0.020mol)에 DMSO 340ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane : methylene chloride)하여 화합물 15를 4.6g(수율 41%) 수득하였다.340 ml of DMSO was added to Intermediate 15-2 (8.6 g, 0.023 mol), Intermediate 1-4 (9.2 g, 0.023 mol), Catalyst Copper (II) (0.44 g, 0.0020 mol) and Potassium fluoride (1.4 g, 0.020 mol) And reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 4.6 g (yield: 41%) of Compound 15.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.50/M, 7.45/M, 7.63/D, 7.29/M, 8.12/D, 7.90/D, 7.39/M, 8.10/D) 2H(6.81/M, 6.69/D, 7.54/D, 7.50/D, 7.58/M) 4H(7.20/M, 6.63/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.63 / D, 7.29 / M, 8.12 / D, 7.90 / D, 7.39 / M, 8.10 / D) 2H (6.81 M, 6.69 / D, 7.54 / D, 7.50 / D, 7.58 /

LC/MS: m/z= 487[(M+1)+] LC / MS: m / z = 487 [(M + 1) < + &

실시예Example 9: 화합물 18 합성 9: Compound 18 Synthesis

(1) (One) 제조예Manufacturing example 9-1: 중간체 18-1 합성 9-1: Synthesis of Intermediate 18-1

Figure 112012107028500-pat00083
Figure 112012107028500-pat00083

4-bromo-9-phenyl-9H-carbazole(10g, 0.031mol, sigma aldrich), 4-bromophenylboronic acid (7.5g, 0.037mol, sigma aldrich), Pd(pph)4(1.0g, 0.0009 mol, sigma Aldrich), NaOH(3.7g, 0.093mol, sigma aldrich )에 THF 360ml를 넣고 질소 하에서 3시간 동안 환류 교반하여 반응시켰다. 반응혼합물을 냉각 시킨 후 dichloromethane 추출 후 실리카 column 정제(MC:HEX)하여 중간체 18-1를 9.1g(수율 74%)수득하였다.4-bromophenylboronic acid (7.5 g, 0.037 mol, Sigma Aldrich), Pd (PPh) 4 (1.0 g, 0.0009 mol, Sigma Aldrich) (10 g, 0.031 mol, Sigma Aldrich) ) And NaOH (3.7 g, 0.093 mol, sigma aldrich), and the mixture was stirred under reflux for 3 hours under nitrogen. The reaction mixture was cooled, extracted with dichloromethane, and purified by silica column (MC: HEX) to obtain 9.1 g (yield: 74%) of intermediate 18-1.

LC/MS: m/z= 398[(M+1)+] LC / MS: m / z = 398 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 9-2: 화합물 18 합성 9-2: Compound 18 Synthesis

Figure 112012107028500-pat00084
Figure 112012107028500-pat00084

중간체 18-1(9.1g, 0.023mol), 9H-pyrido[3,4-b]indol-9-ylboronic acid(5.9g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 18을 8.6g(수율 77%) 수득하였다.(5.9 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29 g, 0.0023 mol) was added to a solution of Intermediate 18-1 (9.1 g, 0.023 mol), 9H- ), 400 ml of DMSO was added to potassium fluoride (1.65 g, 0.023 mol), and the reaction was carried out at 130 ° C. The reaction mixture was cooled, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 77%) of Compound 18.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.45/M, 7.25/M, 8.55/D, 7.33/M, 7.94/D, 7.59/D, 7.43/M) 2H(8.78/S, 9.26/S, 7.68/D, 7.50/D, 7.58/D) 3H(7.79/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.25 / M, 8.55 / D, 7.33 / M, 7.94 / D, 7.59 / D, 7.43 / M) 2H (8.78 / S, 9.26 / S, 7.68 / D, 7.50 / D, 7.58 / D) 3H (7.79 / D)

LC/MS: m/z= 489[(M+1)+] LC / MS: m / z = 489 [(M + 1) < + &

실시예Example 10: 화합물 21 합성 10: Compound 21 Synthesis

Figure 112012107028500-pat00085
Figure 112012107028500-pat00085

중간체 18-1(9.1g, 0.023mol), 4,6-diphenyl-1,3,5-triazin-2-ylboronic acid (7.8g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023 mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 21을 8.6 g(수율 68%) 수득하였다.2-ylboronic acid (7.8 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29 g, 0.023 mol) 0.0023 mol), Potassium fluoride (1.65 g, 0.023 mol) was added with 400 ml of DMSO and reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 68%) of Compound 21.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.25/M, 7.45/M, 7.33/M, 8.55/D, 7.94/D, 7.59/D, 7.43/M, 7.79/D) 2H(7.41/M, 7.85/D, 7.25/D, 7.50/D, 7.58/D) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.25 / M, 7.45 / M, 7.33 / M, 8.55 / D, 7.94 / D, 7.59 / D, 7.43 / M, 7.79 / D) 2H (7.41 7.58 / D, 7.58 / D) 4H (8.28 / D, 7.51 / M)

LC/MS: m/z= 551[(M+1)+] LC / MS: m / z = 551 [(M + 1) < + &

실시예Example 11: 화합물 22 합성 11: Compound 22 Synthesis

Figure 112012107028500-pat00086
Figure 112012107028500-pat00086

중간체 18-1(9.1g, 0.023mol), 43,5-diphenyl-4H-1,2,4-triazol-4-ylboronic acid (7.4g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 22를 8.6 g(69%) 수득하였다.4-ylboronic acid (7.4 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29 g, 0.023 mol), 43.5-diphenyl- g, 0.0023mol) and Potassium fluoride (1.65g, 0.023mol) were added to 400ml of DMSO and reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (69%) of Compound 22.

H-NMR(200MHz, CDCl3): δ ppm, 1H (7.45/M, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 7.43/M) 2H(7.41/M, 7.68/D, 7.50/D, 7.58/M) 3H(7.79/D) 4H(7.51/M, 8.28/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 7.43 / M) 2H (7.41 / M, 7.68 / D, 7.50 / D, 7.58 / M) 3H (7.79 / D) 4H (7.51 / M, 8.28 / D)

LC/MS: m/z=539 [(M+1)+] LC / MS: m / z = 539 [(M + 1) < + &

실시예Example 12: 화합물 23 합성 12: Compound 23 Synthesis

Figure 112012107028500-pat00087
Figure 112012107028500-pat00087

중간체 18-1(9.1g, 0.023mol), 3,5-bis(1-phenyl-1H-benzo[d]imidazol-2-yl)phenylboronic acid (14.2g, 0.028 mo, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 23을 8.6g(수율 48%) 수득하였다.Intermediate 18-1 (9.1 g, 0.023 mol), 3,5-bis (1-phenyl- 1H-benzo [d] imidazol-2-yl) phenylboronic acid (14.2 g, 0.028 mo, sigma aldrich) II) (0.29g, 0.0023mol) and Potassium fluoride (1.65g, 0.023mol), and the reaction was carried out at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 48%) of Compound 23.

H-NMR(200MHz, CDCl3): δ ppm, 1H(8.55/D, 7.33/M, 7.94/D, 7.25/M, 7.43/M, 7.79/D) 2H(8.56/D, 7.58/D) 3H(7.59/D, 7.45/M, 7.66/S) 4H(7.58/M, 7.25/D, 7.22/M) 6H(7.50/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / D, 7.33 / M, 7.94 / D, 7.25 / M, 7.43 / M, 7.79 / D) 2H (8.56 / D, 7.58 / D) 3H (7.59 / D, 7.45 / M, 7.66 / S) 4H (7.58 / M, 7.25 / D, 7.22 /

LC/MS: m/z= 780[(M+1)+] LC / MS: m / z = 780 [(M + 1) < + &

실시예Example 13: 화합물 25 합성 13: Compound 25 Synthesis

Figure 112012107028500-pat00088
Figure 112012107028500-pat00088

중간체 18-1(9.1g, 0.023mol), dipyridin-3-ylboramidic acid (6.0g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 25를 8.6g(수율 77%) 수득하였다.0.025 mol, Sigma aldrich), Catalyst Copper (II) (0.29 g, 0.0023 mol), Potassium fluoride (1.65 g, 0.023 mol), Intermediate 18-1 (9.1 g, 0.023 mol), dipyridin-3-ylboramidic acid ), 400 ml of DMSO was added and reacted at 130 캜. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 77%) of Compound 25.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.45/M, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 7.59/D, 7.43/M, 7.79/D) 2H(7.58/M, 7.50/D, 7.54/D, 6.69/D, 8.04/S, 8.09/D, 7.36/M, 7.27/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 7.59 / D, 7.43 / M, 7.79 / D) 2H (7.58 7.54 / D, 6.69 / D, 8.04 / S, 8.09 / D, 7.36 / M, 7.27 / D)

LC/MS: m/z=489 [(M+1)+] LC / MS: m / z = 489 [(M + 1) < + &

실시예Example 14: 화합물 29 합성 14: Compound 29 Synthesis

Figure 112012107028500-pat00089
Figure 112012107028500-pat00089

중간체 18-1(9.1g, 0.023mol), imidazo[1,2-a]pyridin-7-ylboronic acid (4.5g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml을 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 29를 8.6g(수율 86%) 수득하였다.Imidazo [1,2-a] pyridin-7-ylboronic acid (4.5 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29 g, 0.0023 mol) DMSO (400 ml) was added to potassium fluoride (1.65 g, 0.023 mol) and the reaction was allowed to proceed at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield 86%) of Compound 29.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.25/M, 7.45/M, 7.94/D, 7.33/M, 8.55/D, 7.59/D, 7.43/M, 7.79/D, 7.73/S, 6.87/D, 8.54/D) 2H(7.48/D, 7.50/D, 7.58/M) 4H(7.25/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.25 / M, 7.45 / M, 7.94 / D, 7.33 / M, 8.55 / D, 7.59 / D, 7.43 / M, 7.79 / D, 7.73 / S , 6.87 / D, 8.54 / D) 2H (7.48 / D, 7.50 / D, 7.58 /

LC/MS: m/z= 435[(M+1)+] LC / MS: m / z = 435 [(M + 1) < + &

실시예Example 15: 화합물 30 합성 15: Compound 30 Synthesis

Figure 112012107028500-pat00090
Figure 112012107028500-pat00090

중간체 18-1(9.1g, 0.023mol), 9H-carbazol-9-ylboronic acid (5.9g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29 g, 0.0023 mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 30을 8.6g(수율 63%) 수득하였다.(5.9 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29 g, 0.0023 mol), Potassium fluoride (1.65 g, 0.023 mol), Intermediate 18-1 (9.1 g, 0.023 mol), 9H- 0.03 mol), 400 ml of DMSO was added, and the reaction was allowed to proceed at 130 占 폚. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 63%) of Compound 30.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.50/M, 7.63/D, 7.29/M, 8.12/D, 7.45/M, 7.59/D, 7.43/M) 2H(7.50/D, 7.68/D, 7.58/M, 7.94/D, 7.33/M, 7.25/M, 8.55/D) 3H(7.79/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.63 / D, 7.29 / M, 8.12 / D, 7.45 / M, 7.59 / D, 7.43 / M) 2H (7.50 / D, 7.68 / D, 7.58 / M, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D)

LC/MS: m/z=485 [(M+1)+] LC / MS: m / z = 485 [(M + 1) < + &

실시예Example 16: 화합물 31 합성 16: Compound 31 Synthesis

Figure 112012107028500-pat00091
Figure 112012107028500-pat00091

중간체 18-1(9.1g, 0.023mol), 2,7-bis(9-phenyl-9H-fluoren-9-yl)-9H-carbazol-9-ylboronic acid (18.9, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29 g, 0.0023 mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 31을 15.9g(수율 69%) 수득하였다.9-yl) -9H-carbazol-9-ylboronic acid (18.9, 0.028 mol, sigma aldrich), 9.1 g DMSO (400 ml) was added to Copper (II) (0.29 g, 0.0023 mol) and Potassium fluoride (1.65 g, 0.023 mol) After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 15.9 g (yield: 69%) of Compound 31.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.28/D, 7.45/M, 7.59/D, 7.43/M, 7.55/S, 7.31/D, 8.00/D, 8.31/D, 6.80/D, 7.20/D) 2H(7.50/D, 7.55/D, 7.68/M, 7.58/M, 8.55/D, 8.55/S) 3H(7.28/M, 7.79/D) 4H(7.11/D, 7.87/D, 7.38/M) 5H(7.33/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.28 / D, 7.45 / M, 7.59 / D, 7.43 / M, 7.55 / S, 7.31 / D, 8.00 / D, 8.31 / D, 6.80 / D , 7.20 / D) 2H (7.50 / D, 7.55 / D, 7.68 / M, 7.58 / M, 8.55 / D, 8.55 / , 7.38 / M) 5H (7.33 / M)

LC/MS: m/z= 966[(M+1)+] LC / MS: m / z = 966 [(M + 1) < + &

실시예Example 17: 화합물 34 합성 17: Compound 34 Synthesis

Figure 112012107028500-pat00092
Figure 112012107028500-pat00092

중간체 18-1(9.1g, 0.023mol), 4,6-diphenyl-1,3,5-triazin-2-ylboronic acid (7.8g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 34를 8.6g(수율 68%) 수득하였다.2-ylboronic acid (7.8 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29 g, 0.023 mol) 0.0023 mol), and potassium fluoride (1.65 g, 0.023 mol) were added to 400 ml of DMSO and reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 68%) of Compound 34.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.25/M, 7.45/M, 7.94/D, 7.33/M, 8.55/D, 7.59/D, 7.43/M, 7.79/D) 2H(7.25/D, 7.85/D, 7.41/M, 7.58/M, 7.50/D) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.25 / M, 7.45 / M, 7.94 / D, 7.33 / M, 8.55 / D, 7.59 / D, 7.43 / M, 7.79 / D) 2H (7.25 / D, 7.85 / D, 7.41 / M, 7.58 / M, 7.50 / D)

LC/MS: m/z= 551[(M+1)+] LC / MS: m / z = 551 [(M + 1) < + &

실시예Example 18: 화합물 35 합성 18: Compound 35 Synthesis

Figure 112012107028500-pat00093
Figure 112012107028500-pat00093

중간체 18-1(9.1g, 0.023mol), 2,6-diphenylpyridin-4-ylboronic acid (7.7g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 35를 10.1g(수율 80%) 수득하였다.(7.9 g, 0.028 mol, Sigma aldrich), Catalyst Copper (II) (0.29 g, 0.0023 mol), Potassium fluoride (1.65 g, 0.023 mol), Intermediate 18-1 (9.1 g, 0.023 mol), 2,6-diphenylpyridin- g, 0.023 mol), 400 ml of DMSO was added, and the reaction was allowed to proceed at 130 占 폚. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 10.1 g (yield 80%) of Compound 35.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.45/M, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 7.59/D, 7.43/M, 7.79/D) 2H(8.20/S, 7.47/M, 7.50/D, 7.58/M) 4H(8.30/M, 7.54/M, 7.25/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 7.59 / D, 7.43 / M, 7.79 / D) 2H (8.20 7.50 / D, 7.58 / M) 4H (8.30 / M, 7.54 / M, 7.25 / D)

LC/MS: m/z= 549[(M+1)+] LC / MS: m / z = 549 [(M + 1) < + &

실시예Example 19: 화합물 39 합성 19: Compound 39 Synthesis

Figure 112012107028500-pat00094
Figure 112012107028500-pat00094

중간체 18-1(9.1g, 0.023mol), 5-(9H-carbazol-9-yl)-2-phenyl-1H-benzo[d]imidazol-1-ylboronic acid (11.3g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 400ml 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 39를 9.1g(수율 62%) 수득하였다.D] imidazol-1-ylboronic acid (11.3 g, 0.028 mol, Sigma aldrich) was added to a solution of intermediate 18-1 (9.1 g, 0.023 mol) , 400 ml of DMSO was added to Catalyst Copper (II) (0.29 g, 0.0023 mol) and Potassium fluoride (1.65 g, 0.023 mol), and the reaction was carried out at 130 ° C. After cooling the reaction mixture, 400 ml of water was added thereto, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 9.1 g (yield: 62%) of Compound 39.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.45/M, 7.90/D, 7.39/M, 8.10/D, 7.59/D, 7.15/D, 8.55/D, 7.25/M, 7.33/M, 7.94/D, 7.70/S, 7.41/M) 2H(7.50/M, 7.50/D, 7.79/D, 7.68/D, 8.28/D, 7.51/M, 7.58/M, 7.29/M, 8.12/D, 7.63/D)D, 7.25 / M, 7.33 / M (1 H-NMR (200 MHz, CDCl 3 ):? Ppm, 1H (7.45 / M, 7.90 / D, 7.39 / 7.50 / D, 7.79 / D, 7.70 / D, 7.70 / S, 7.41 / M) 2H (7.50 / M, 7.50 / D, 7.79 / D, 7.68 / D, 8.28 / D, 7.51 / M, 7.58 / , 7.63 / D)

LC/MS: m/z=677.81[(M+1)+] LC / MS: m / z = 677.81 [(M + 1) < + &

실시예Example 20: 화합물 44 합성 20: Compound 44 Synthesis

Figure 112012107028500-pat00095
Figure 112012107028500-pat00095

중간체 18-1(9.1g, 0.023mol), triphenylen-2-ylboronic acid (7.6g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 44를 8.8g(수율 70%) 수득하였다.(7.6 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29 g, 0.0023 mol), Potassium fluoride (1.65 g, 0.023 mol), triphenylen-2-ylboronic acid ), 400 ml of DMSO was added, and the reaction was allowed to proceed at 130 占 폚. The reaction mixture was cooled, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.8 g (yield 70%) of Compound 44.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.45/M, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 7.59/D, 7.43/M, 7.79/D, 9.15/S, 8.04/D, 8.18/D) 2H(8.12/D, 7.82/M, 7.88/M, 8.93/D, 7.58/M, 7.50/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 7.59 / D, 7.43 / M, 7.79 / D, 9.15 / S , 8.04 / D, 8.18 / D) 2H (8.12 / D, 7.82 / M, 7.88 / M, 8.93 / D, 7.58 / M, 7.50 / D)

LC/MS: m/z= 546[(M+1)+] LC / MS: m / z = 546 [(M + 1) < + &

실시예Example 21: 화합물 46 합성 21: Compound 46 Synthesis

Figure 112012107028500-pat00096
Figure 112012107028500-pat00096

중간체 18-1(9.1g, 0.023mol), 9,9-diphenyl-9H-fluoren-2-ylboronic acid (10.1g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 46을 9.0g(수율 62%) 수득하였다.(9.1 g, 0.023 mol), 9,9-diphenyl-9H-fluoren-2-ylboronic acid (10.1 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29 g, 0.0023 mol) DMSO (400 ml) was added to potassium fluoride (1.65 g, 0.023 mol) and the reaction was carried out at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 9.0 g of Compound 46 (yield: 62%).

H-NMR(200MHz, CDCl3): δ ppm, 1H (7.50/M, 7.45/M, 7.29/M, 8.12/D, 7.90/D, 7.39/M, 8.10/D, 7.77/S, 7.93/D, 7.87/D, 7.38/M, 7.28/M, 7.55/D) 2H(7.50/D, 7.58/M, 7.63/D, 7.26/M) 4H(7.11/D, 7.33/M, 7.25/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.29 / M, 8.12 / D, 7.90 / D, 7.39 / M, 8.10 / D, 7.77 / S, 7.93 / D D, 7.58 / M, 7.63 / D, 7.26 / M) 4H (7.11 / D, 7.33 / M, 7.25 / D)

LC/MS: m/z= 636[(M+1)+] LC / MS: m / z = 636 [(M + 1) < + &

실시예Example 22: 화합물 56 합성 22: Compound 56 Synthesis

Figure 112012107028500-pat00097
Figure 112012107028500-pat00097

중간체 18-1(9.1g, 0.023mol), 4-(9H-carbazol-9-yl)phenyl(biphenyl-4-yl)boramidic acid(12.7g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023 mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 56을 10.4g(수율 62%) 수득하였다.4- (9H-carbazol-9-yl) phenyl (biphenyl-4-yl) boramidic acid (12.7g, 0.028mol, sigma aldrich), Catalyst Copper (II) 0.29g, 0.0023mol) and Potassium fluoride (1.65g, 0.023mol), and the mixture was reacted at 130 占 폚. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 10.4 g (yield: 62%) of Compound 56.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.41/M, 7.63/D, 7.50/M, 7.29/M, 8.12/D, 7.45/M, 7.59/D, 7.43/M, 7.79/D) 2H(7.58/M, 7.50/D, 7.54/D, 6.63/D, 7.37/D, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 7.51/M, 7.52/D, 7.54/M) 4H(6.69/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / M, 7.63 / D, 7.50 / M, 7.29 / M, 8.12 / D, 7.45 / M, 7.59 / D, 7.43 / M, 7.79 / D 7.55 / D, 7.54 / D, 7.37 / D, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 7.51 / M, 7.52 / ) 4H (6.69 / D)

LC/MS: m/z= 728[(M+1)+] LC / MS: m / z = 728 [(M + 1) < + &

실시예Example 23: 화합물 60 합성 23: Compound 60 Synthesis

Figure 112012107028500-pat00098
Figure 112012107028500-pat00098

중간체 18-1(9.1g, 0.023mol), 9,9-diphenyl-9H-fluoren-2-yl(triphenylen-2-yl)boramidic acid(16.9g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 60을 14.2g(수율 70%) 수득하였다.2-yl) boramidic acid (16.9 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (9.1 g, 0.023 mol), 9,9- (0.29g, 0.0023mol) and Potassium fluoride (1.65g, 0.023mol), and the mixture was reacted at 130 占 폚. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and purified by column (n-hexane: methylene chloride) to obtain 14.2 g (yield 70%) of Compound 60.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.45/M, 7.94/D, 7.25/M, 8.55/D, 7.59/D, 7.43/M, 7.79/D, 7.02/D, 8.13/S, 6.58/D, 7.62/D, 6.75/D, 7.55/D, 7.28/M, 7.38/M) 2H(8.12/D, 7.82/M, 7.88/M, 8.93/D, 7.50/D, 7.58/M, 7.54/D, 6.69/D, 7.26/M, 7.87/D) 4H(7.11/D) 5H(7.33/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.94 / D, 7.25 / M, 8.55 / D, 7.59 / D, 7.43 / M, 7.79 / D, 7.02 / D, 8.13 / S D, 7.62 / D, 6.75 / D, 7.55 / D, 7.28 / M, 7.38 / , 7.54 / D, 6.69 / D, 7.26 / M, 7.87 / D) 4H (7.11 / D)

LC/MS: m/z= 878[(M+1)+] LC / MS: m / z = 878 [(M + 1) < + &

실시예Example 24: 화합물 64 합성 24: Compound 64 Synthesis

Figure 112012107028500-pat00099
Figure 112012107028500-pat00099

중간체 18-1(9.1g, 0.023mol), 4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl(triphenylen-2-yl)boramidic acid(16.6g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 64를 15.1g(수율 76%) 수득하였다.Intermediate 18-1 (9.1 g, 0.023 mol), 4- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl (triphenylen-2-yl) boramidic acid (16.6 g, 0.028 mol, 400ml of DMSO was added to the catalyst Copper (II) (0.29g, 0.0023mol) and potassium fluoride (1.65g, 0.023mol), and the reaction was carried out at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 15.1 g (yield: 76%) of Compound 64.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.45/M, 7.59/D, 7.43/M, 7.79/D, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 7.02/D, 7.87/D, 8.13/S) 2H(8.93/D, 7.88/M, 7.82/M, 8.12/D, 7.41/M, 7.90/D, 7.54/D, 7.50/D, 7.58/M) 4H(7.51/M, 8.28/D, 6.69/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.59 / D, 7.43 / M, 7.79 / D, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 7.02 / D D, 7.50 / D, 7.58 / M) 4H (7.51 / 7.87 / D, 8.13 / S) 2H (8.93 / D, 7.88 / M, 7.82 / / M, 8.28 / D, 6.69 / D)

LC/MS: m/z= 869[(M+1)+] LC / MS: m / z = 869 [(M + 1) < + &

실시예Example 25: 화합물 72 합성 25: Compound 72 Synthesis

Figure 112012107028500-pat00100
Figure 112012107028500-pat00100

중간체 18-1(9.1g, 0.023mol), biphenyl-4-yl(9,9-diphenyl-9H-fluoren-2-yl)boramidic acid (12.2g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 72를 15.4g(수율 83%) 수득하였다.4-yl (9,9-diphenyl-9H-fluoren-2-yl) boramidic acid (12.2 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29g, 0.0023mol) and Potassium fluoride (1.65g, 0.023mol), and the mixture was reacted at 130 占 폚. The reaction mixture was cooled, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 15.4 g (yield 83%) of Compound 72.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.45/M, 7.59/D, 7.43/M, 7.79/D, 7.94/D, 7.25/M, 8.55/D, 6.75/D, 6.58/D, 7.62/D, 7.87/D, 7.38/M, 7.28/M, 7.55/D, 7.41/M) 2H(7.50/D, 7.58/M, 7.51/M, 7.52/D, 7.26/M) 4H(7.11/D, 7.54/D, 6.69/D) 5H(7.33/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.59 / D, 7.43 / M, 7.79 / D, 7.94 / D, 7.25 / M, 8.55 / D, 6.75 / D, 6.58 / D (7.50 / D, 7.58 / M, 7.51 / M, 7.52 / D, 7.26 / M) / D, 7.54 / D, 6.69 / D) 5H (7.33 / M)

LC/MS: m/z= 804[(M+1)+] LC / MS: m / z = 804 [(M + 1) < + &

실시예Example 26: 화합물 77 합성 26: Compound 77 Synthesis

Figure 112012107028500-pat00101
Figure 112012107028500-pat00101

중간체 18-1(9.1g, 0.023mol), 3-(9H-carbazol-9-yl)phenyl(biphenyl-4-yl)boramidic acid(12.7g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 77을 8.6g(수율 51%) 수득하였다.4-yl) boramidic acid (12.7 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (11.2 g, 0.023 mol) 0.29g, 0.0023mol) and Potassium fluoride (1.65g, 0.023mol), and the reaction was carried out at 130 占 폚. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 51%) of Compound 77.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.50/M, 7.45/M, 7.59/D, 7.43/M, 7.79/D, 7.41/M, 6.63/D, 7.20/M, 6.86/D, 7.63/D, 6.50/S, 7.29/M, 8.12/D) 2H(7.50/D, 7.51/M, 7.52/D, 7.58/M, 7.94/D, 7.33/M, 7.25/M, 8.55/D) 4H(7.54/D, 6.69/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.59 / D, 7.43 / M, 7.79 / D, 7.41 / M, 6.63 / D, 7.20 / M, 6.86 / D 7.50 / D, 7.51 / M, 7.94 / D, 7.33 / M, 7.25 / M, ) ≪ / RTI > 4H (7.54 / D, 6.69 / D)

LC/MS: m/z=728 [(M+1)+] LC / MS: m / z = 728 [(M + 1) < + &

실시예Example 27: 화합물  27: Compound 80합성80 synthesis

Figure 112012107028500-pat00102
Figure 112012107028500-pat00102

중간체 18-1(9.1g, 0.023mol), naphthalen-2-yl(triphenylen-2-yl)boramidic acid (11.6g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 80을 8.6g(수율 54%) 수득하였다.2-yl) boramidic acid (11.6 g, 0.028 mol, sigma aldrich), Catalyst Copper (II) (0.29 g, 0.0023 mol), and Naphthalen- DMSO (400 ml) was added to potassium fluoride (1.65 g, 0.023 mol) and the reaction was carried out at 130 ° C. The reaction mixture was cooled, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 54%) of Compound 80.

H-NMR(200MHz, CDCl3): δ ppm, 1H(7.50/M, 7.45/M, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 7.59/D, 7.43/M, 7.79/D, 7.02/D, 7.87/D, 8.13/S, 7.49/D, 7.84/D, 7.88/D, 7.36/M, 7.77/D, 7.74/S) 2H(8.93/D, 7.88/M, 7.82/M, 8.12/D, 7.54/D, 6.69/D, 7.50/D, 7.58/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 7.59 / D, 7.43 / M, 7.79 / D , 7.02 / D, 7.87 / D, 8.13 / S, 7.49 / D, 7.84 / D, 7.88 / D, 7.36 / , 8.12 / D, 7.54 / D, 6.69 / D, 7.50 / D, 7.58 / M)

LC/MS: m/z= 687[(M+1)+] LC / MS: m / z = 687 [(M + 1) < + &

실시예Example 28: 화합물 83 합성 28: Compound 83 Synthesis

Figure 112012107028500-pat00103
Figure 112012107028500-pat00103

중간체 18-1(9.1g, 0.023mol), dibenzo[b,d]thiophen-3-yl(naphthalen-2-yl)boramidic acid(10.0g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 83을 8.6g(수율 58%) 수득하였다.(9.1 g, 0.023 mol), dibenzo [b, d] thiophen-3-yl (naphthalen-2-yl) boramidic acid (10.0 g, 0.028 mol, sigma aldrich), Catalyst Copper g, 0.0023mol) and Potassium fluoride (1.65g, 0.023mol) were added to 400ml of DMSO and reacted at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 8.6 g (yield: 58%) of Compound 83.

H-NMR(200MHz, CDCl3): δ ppm, 1H (7.45/M, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 7.59/D, 7.43/M, 7.79/D, 7.98/D, 7.52/M, 8.45/D, 7.36/M, 7.88/D, 7.81/D, 7.27/D, 6.86/D, 7.49/D, 7.84/D, 7.74/S, 7.77/D) 2H(7.50/M, 7.50/D, 6.69/D, 7.58/M, 7.54/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 7.59 / D, 7.43 / M, 7.79 / D, 7.98 / D , 7.52 / M, 8.45 / D, 7.36 / M, 7.88 / D, 7.81 / D, 7.27 / D, 6.86 / D, 7.49 / D, 7.84 / D, 7.74 / , 7.50 / D, 6.69 / D, 7.58 / M, 7.54 / D)

LC/MS: m/z= 643[(M+1)+] LC / MS: m / z = 643 [(M + 1) < + &

실시예Example 29: 화합물 89 합성 29: Compound 89 Synthesis

Figure 112012107028500-pat00104
Figure 112012107028500-pat00104

중간체 18-1(9.1g, 0.023mol), dibenzo[b,d]thiophen-2-yl(phenyl)boramidic acid (8.9g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 89를 9.0g(수율 66%) 수득하였다.(8.9g, 0.028mol, sigma aldrich), Catalyst Copper (II) (0.29g, 0.0023mol) were added to a solution of intermediate 18-1 (9.1g, 0.023mol), dibenzo [b, d] thiophen- ), 400 ml of DMSO was added to potassium fluoride (1.65 g, 0.023 mol), and the reaction was carried out at 130 캜. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and purified by column (n-hexane: methylene chloride) to obtain 9.0 g (yield: 66%) of Compound 89.

H-NMR(200MHz, CDCl3): δ ppm, 1H (7.50/M, 7.45/M, 7.33/M, 7.94/D, 7.59/D, 7.43/M, 7.79/D, 7.98/D, 7.98/D, 8.55/D, 8.45/D, 7.52/M, 6.88/D, 6.63/D, 7.34/D) 2H(7.50/D, 6.63/D, 7.54/D, 7.58/M, 7.25/M, 7.20/M, 6.69/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.50 / M, 7.45 / M, 7.33 / M, 7.94 / D, 7.59 / D, 7.43 / M, 7.79 / D, 7.98 / D, 7.98 / D M, 7.25 / M, 7.20 / M, 8.55 / D, 8.45 / D, 7.52 / M, 6.88 / D, 6.63 / D, 7.34 / , 6.69 / D)

LC/MS: m/z= 593[(M+1)+] LC / MS: m / z = 593 [(M + 1) < + &

실시예Example 30: 화합물 90 합성 30: Compound 90 Synthesis

(1) (One) 제조예Manufacturing example 30-1: 중간체 90-1 합성 30-1: Synthesis of intermediate 90-1

Figure 112012107028500-pat00105
Figure 112012107028500-pat00105

중간체 1-4(8.5g, 0.023mol), 6-bromonaphthalen-2-ylboronic acid (8.0g, 0.028mol, sigma aldrich), 촉매 Copper(II)(0.29g, 0.0023mol), Potassium fluoride(1.65g, 0.023mol)에 DMSO 400ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 중간체 90-1을 7.5g(수율 73%) 수득하였다(0.2 g, 0.0023 mol), Potassium fluoride (1.65 g, 0.023 mol), Intermediate 1-4 (8.5 g, 0.023 mol), 6-bromonaphthalen-2-ylboronic acid (8.0 g, 0.028 mol, sigma aldrich) 0.03 mol), 400 ml of DMSO was added, and the reaction was allowed to proceed at 130 占 폚. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 7.5 g (yield 73%) of Intermediate 90-1

(2) (2) 제조예Manufacturing example 30-2: 화합물 90 합성 30-2: Compound 90 Synthesis

Figure 112012107028500-pat00106
Figure 112012107028500-pat00106

중간체 90-1(7.5g, 0.016mol), 9-phenyl-9H-carbazol-4-ylboronic acid (5.7g, 0.020mol, sigma aldrich), 촉매 Copper(II)(0.20g, 0.0016mol), Potassium fluoride(1.14g, 0.023mol)에 DMSO 300ml를 넣고 130℃에서 반응시켰다. 반응 혼합물을 냉각시킨 후 물을 반응 용매량 만큼 첨가하여 추출 후 칼럼 정제(n-Hexane: methylene chloride)하여 화합물 90을 6.5g(수율 67%) 수득하였다.A mixture of Intermediate 90-1 (7.5 g, 0.016 mol), 9-phenyl-9H-carbazol-4-ylboronic acid (5.7 g, 0.020 mol, sigma aldrich), Catalyst Copper (II) (0.20 g, 0.0016 mol) (1.14 g, 0.023 mol) was added 300 ml of DMSO and the reaction was carried out at 130 ° C. After cooling the reaction mixture, water was added by the amount of the reaction solvent, and the mixture was extracted and subjected to column purification (n-hexane: methylene chloride) to obtain 6.5 g (yield 67%) of Compound 90.

H-NMR(200MHz, CDCl3): δ ppm, 2H(8.55/D, 7.33/M, 7.58/S, 7.94/D, 7.25/D, 7.45/M, 7.59/D, 7.43/M, 7.79/D, 7.73/D, 7.92/D) 4H(7.50/D, 7.58/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 2H (8.55 / D, 7.33 / M, 7.58 / S, 7.94 / D, 7.25 / D, 7.45 / M, 7.59 / D, 7.43 / M, 7.79 / D , 7.73 / D, 7.92 / D) 4H (7.50 / D, 7.58 / M)

LC/MS: m/z= 611[(M+1)+] LC / MS: m / z = 611 [(M + 1) < + &

본 발명의 실시예에서 쓰이는 약어는 아래와 같다.Abbreviations used in the embodiment of the present invention are as follows.

NPB: N,N'-Bis(naphthalen-1-yl)-N,N'-bis(phenyl)benzidineNPB: N, N'-bis (naphthalen-1-yl) -N,

Ir(ppy)3: Iridium, tris(2-phenylpyidine)Ir (ppy) 3 : Iridium, tris (2-phenylpyidine)

Balq: Bis(2-methyl-8-quinolinolato-N1,O8)-(1,1'-Biphenyl-4-olato)aluminumBalq: Bis (2-methyl-8-quinolinolato-N1, O8) - (1,1'-Biphenyl-4-olato) aluminum

Alq3: tris(8-quinolinolato)-aluminium(III)Alq 3 : tris (8-quinolinolato) -aluminium (III)

CBP: (4,4-N,N-dicarbazole)biphenyl
CBP: (4,4-N, N-dicarbazole) biphenyl

소자실시예Device Example 1: 화합물 1을  1: Compound 1 발광층의The light- 호스트 재료로 하여  As a host material 유기전계발광소자Organic electroluminescent device 제조 Produce

ITO로 코팅된 유리기판 위에 NPB를 증착하여 120nm의 정공수송층을 형성하였으며, 이어서 Ir(ppy)3을 도펀트로 하여 화합물 1을 9% 속도(rate), 즉 화합물 1 의 증착속도를 0.1nm/sec, Ir(ppy)3 증착속도를 0.009nm/sec로 증착하여 증착속도 비율이 8%가 되도록 Ir(ppy)3을 도핑하여 정공수송층 상에 발광층을 30nm 두께로 형성하였다. 그 위에 Balq를 10nm 두께로 증착하여 정공이 발광층을 지나 전자수송층으로 이동하는 것을 방지하는 정공차단층을 형성하고, 그 위에 Alq3를 증착하여 40nm두께의 전자수송층을 형성하였으며, 그 위에 불화리튬을 증착하여 1nm두께의 전자주입층을 형성하였다. 전자주입층 상에 알루미늄을 증착하여 120nm의 음극을 형성하여 유기전계발광소자를 제조하였다.NPB was deposited on a glass substrate coated with ITO to form a hole transporting layer having a thickness of 120 nm and then Compound 1 was doped with Ir (ppy) 3 at a rate of 9%, that is, a deposition rate of Compound 1 was 0.1 nm / sec And Ir (ppy) 3 were deposited at a deposition rate of 0.009 nm / sec. Ir (ppy) 3 was doped to a deposition rate ratio of 8% to form a light emitting layer having a thickness of 30 nm on the hole transport layer. Balq was deposited thereon to a thickness of 10 nm to form a hole blocking layer to prevent holes from moving to the electron transporting layer through the light emitting layer, and Alq 3 was deposited thereon to form an electron transporting layer having a thickness of 40 nm. Lithium fluoride Thereby forming an electron injection layer having a thickness of 1 nm. Aluminum was deposited on the electron injecting layer to form a 120 nm cathode, thereby fabricating an organic electroluminescent device.

이때, 각 물질의 증착속도는 유기물질인, 화합물 1, NPB, Alq3, Balq는 0.1 nm/sec의 속도로 증착하였고, 불화리튬은 0.01 nm/sec, 알루미늄은 0.5 nm/sec의 속도로 증착하였다.At this time, the deposition rate of each material was evaporated at a rate of 0.1 nm / sec for the compound 1, NPB, Alq 3 , and Balq, 0.01 nm / sec for lithium fluoride, and 0.5 nm / sec for aluminum Respectively.

소자실시예Device Example 2 내지 26 2 to 26

화합물 1 대신에 하기 표 1에 기재된 발광재료로 사용한 것을 제외하고는 소자실시예1과 동일한 방법으로 소자실시예 2 내지 14의 유기전계발광소자를 제조하였다.The organic electroluminescent devices of the device embodiments 2 to 14 were fabricated in the same manner as in the device example 1 except that the compound 1 was used instead of the luminescent material described in the following Table 1. [

소자실시예Device Example 27 27

화합물 1 대신 호스트 물질로서 CBP((4,4-N,N-dicarbazole)biphenyl)를 사용하고, 정공수송물질로서 NPB 대신 화합물6을 사용한 것을 제외하고 소자실시예 1과 동일한 방법으로 유기전계발광소자를 제조하였다.Except that CBP ((4,4-N, N-dicarbazole) biphenyl) was used as a host material instead of Compound 1 and Compound 6 was used instead of NPB as a hole transporting material. .

소자실시예Device Example 28 내지 35 28 to 35

화합물 6 대신에 하기 표 1에 기재된 정공수송재료로 사용한 것을 제외하고는 소자실시예27과 동일한 방법으로 소자실시예 28 내지 35의 유기전계발광소자를 제조하였다.Organic electroluminescent devices of Device Examples 28 to 35 were fabricated in the same manner as in Example 27 except that the compound 6 was replaced with the hole transport material shown in Table 1 below.

소자비교예Device comparison example 1 One

상기 화합물 1 대신 (4,4-N,N-dicarbazole)biphenyl (CBP)를 발광재료로 사용한 것을 제외하고는 소자실시예 1과 동일한 방법으로 유기전계발광소자를 제조하였다.
An organic electroluminescent device was prepared in the same manner as in Example 1 except that (4,4-N, N-dicarbazole) biphenyl (CBP) was used as a light emitting material instead of the compound 1.

이하, 상기 소자실시예 1 내지 35와 소자비교예 1에 따라 제조된 유기전계발광소자의 특성을 비교한 결과를 하기 표 1에 나타내었다.Hereinafter, the characteristics of the organic electroluminescent devices manufactured according to the device embodiments 1 to 35 and the device comparative example 1 are shown in Table 1 below.

발광재료
(호스트)
Emitting material
(Host)
정공수송재료Hole transport material 구동전압
(V at 1000cd/m2)
Driving voltage
(V at 1000 cd / m 2 )
발광효율
(cd/A)
Luminous efficiency
(cd / A)
color
소자실시예 1Device Embodiment 1 화합물1Compound 1 NPBNPB 5.15.1 3535 녹색green 소자실시예 2Device Example 2 화합물2Compound 2 NPBNPB 5.95.9 3030 녹색green 소자실시예 3Device Embodiment 3 화합물5Compound 5 NPBNPB 6.06.0 2525 녹색green 소자실시예 4Device Example 4 화합물6Compound 6 NPBNPB 5.45.4 2222 녹색green 소자실시예 5Element Embodiment 5 화합물7Compound 7 NPBNPB 4.54.5 2525 녹색green 소자실시예 6Device Example 6 화합물12Compound 12 NPBNPB 5.95.9 2626 녹색green 소자실시예 7Device Example 7 화합물 14Compound 14 NPBNPB 5.25.2 2727 녹색green 소자실시예 8Device Example 8 화합물 15Compound 15 NPBNPB 5.55.5 3131 녹색green 소자실시예 9Device Example 9 화합물 18Compound 18 NPBNPB 5.15.1 2727 녹색green 소자실시예 10Element Embodiment 10 화합물 21Compound 21 NPBNPB 5.45.4 2929 녹색green 소자실시예 11Element Embodiment 11 화합물 22Compound 22 NPBNPB 5.55.5 2222 녹색green 소자실시예 12Device Example 12 화합물 23Compound 23 NPBNPB 5.05.0 3434 녹색green 소자실시예 13Device Embodiment 13 화합물 29Compound 29 NPBNPB 4.94.9 3030 녹색green 소자실시예 14Device Embodiment 14 화합물 30Compound 30 NPBNPB 5.75.7 2020 녹색green 소자실시예 15Device Example 15 화합물 31Compound 31 NPBNPB 5.75.7 2424 녹색green 소자실시예 16Device Embodiment 16 화합물 34Compound 34 NPBNPB 5.95.9 2525 녹색green 소자실시예 17Device Example 17 화합물 35Compound 35 NPBNPB 5.65.6 2626 녹색green 소자실시예 18Element Embodiment 18 화합물 39Compound 39 NPBNPB 5.75.7 2424 녹색green 소자실시예 19Element Embodiment 19 화합물 44Compound 44 NPBNPB 5.85.8 2828 녹색green 소자실시예 20Device Embodiment 20 화합물 46Compound 46 NPBNPB 5.85.8 2626 녹색green 소자실시예 21Device Example 21 화합물 56 Compound 56 NPBNPB 6.06.0 2525 녹색green 소자실시예 22Device Embodiment 22 화합물 60 Compound 60 NPBNPB 6.16.1 2020 녹색green 소자실시예 23Device Example 23 화합물 64Compound 64 NPBNPB 5.25.2 2222 녹색green 소자실시예 24Device Embodiment 24 화합물 72Compound 72 NPBNPB 5.95.9 2121 녹색green 소자실시예 25Device Example 25 화합물 77Compound 77 NPBNPB 5.85.8 2323 녹색green 소자실시예 26Device Embodiment 26 화합물 80Compound 80 NPBNPB 5.45.4 2626 녹색green 소자실시예 27Device Example 27 CBPCBP 화합물 6Compound 6 5.55.5 2222 녹색green 소자실시예 28Device Example 28 CBPCBP 화합물 15Compound 15 6.06.0 2121 녹색green 소자실시예 29Element Embodiment 29 CBPCBP 화합물 25Compound 25 5.45.4 2222 녹색green 소자실시예 30Device Example 30 CBPCBP 화합물 56Compound 56 5.45.4 2222 녹색green 소자실시예 31Element Embodiment 31 CBPCBP 화합물 64Compound 64 5.35.3 2020 녹색green 소자실시예 32Device Example 32 CBPCBP 화합물 77Compound 77 5.85.8 2222 녹색green 소자실시예 33Device Example 33 CBPCBP 화합물 80Compound 80 5.45.4 2121 녹색green 소자실시예 34Device Example 34 CBPCBP 화합물 83Compound 83 5.25.2 2121 녹색green 소자실시예 35Device Example 35 CBPCBP 화합물 89Compound 89 5.95.9 2020 녹색green 소자비교예1Device Comparative Example 1 CBPCBP NPBNPB 7.57.5 1717 녹색green

구동전압 및 발광효율 측정Measurement of driving voltage and luminous efficiency

위에서 만든 유기발광소자(기판크기: 25×25mm2/증착면적: 2×2mm2)를 IVL 측정셋트(CS-2000+지그+IVL프로그램)에 고정 한 후 전류를 1mA/m2씩 상승시키며 증착면의 발광 휘도(cd/m2), 구동전압(V), 전류밀도(A/m2), 발광효율(cd/A)을 측정하여 휘도가 1000cd/m2 일 때 구동전압과 발광효율을 상기 표 1에 나타내었다.The organic light emitting element made from above (substrate size: 25 × 25mm 2 / deposition area: 2 × 2mm 2) an IVL measuring set (CS-2000 + fixture + IVL program) depositing sikimyeo a current rise by 1mA / m 2 and then fixed to the the brightness of light emitted by the surface (cd / m 2), a driving voltage (V), current density (a / m 2), luminous efficiency (cd / a) drive voltage when measured brightness is 1000cd / m 2 days and luminous efficiency Shown in Table 1 above.

표 1에 따르면, 본 발명에 따른 유기전계발광소자용 화합물이 유기전계발광소자의 발광층의 호스트 물질로 사용되거나 정공수송재료로 사용될 때 종래의 CBP를 발광재료로 사용하거나, NPB를 정공수송재료로 사용할 때보다 구동전압은 상당히 떨어지고, 발광효율은 상당히 향상된 것을 알 수 있다.According to Table 1, when the compound for an organic electroluminescence device according to the present invention is used as a host material of a light emitting layer of an organic electroluminescent device or as a hole transport material, conventional CBP may be used as a light emitting material, or NPB may be used as a hole transporting material The driving voltage is considerably lower than that in use, and the luminous efficiency is remarkably improved.

Claims (7)

하기 구조식 1 또는 2로 표시되는 유기전계발광소자용 화합물로서, 상기 구조식 1 및 2는 하기 구조식 1-1 및 2-1로 각각 표시되는 유기전계발광소자용 화합물.
Figure 112015000945008-pat00218

Figure 112015000945008-pat00219

상기 구조식 1-1 및 2-1에서,
R4 는 수소원자이고,
R5 및 R6은 서로 같거나 다를 수 있고, R5 및 R6은 각각 독립적으로
Figure 112015000945008-pat00220
,
Figure 112015000945008-pat00221
,
Figure 112015000945008-pat00222
,
Figure 112015000945008-pat00223
,
Figure 112015000945008-pat00224
,
Figure 112015000945008-pat00225
,
Figure 112015000945008-pat00226
,
Figure 112015000945008-pat00227
,
Figure 112015000945008-pat00228
,
Figure 112015000945008-pat00229
,
Figure 112015000945008-pat00230
,
Figure 112015000945008-pat00231
,
Figure 112015000945008-pat00232
,
Figure 112015000945008-pat00233
,
Figure 112015000945008-pat00234
,
Figure 112015000945008-pat00235
,
Figure 112015000945008-pat00236
,
Figure 112015000945008-pat00237
,
Figure 112015000945008-pat00238
,
Figure 112015000945008-pat00239
,
Figure 112015000945008-pat00240
,
Figure 112015000945008-pat00241
, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C1 내지 C30 헤테로아릴기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기이거나, 또는 R5 및 R6 중 적어도 어느 하나는 그 어느 하나가 결합된 탄소원자의 이웃한 탄소원자와 추가로 결합하여 치환 또는 비치환된 융합된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 융합된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 융합된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 융합된 C1 내지 C30 헤테로 아릴기를 형성할 수 있고,
X1 내지 X18, 및 X23 내지 X37은 서로 같거나 다를 수 있고, X1 내지 X18, 및 X23 내지 X37은 각각 독립적으로 질소원자, 또는
Figure 112015000945008-pat00242
이고,
Y1 내지 Y13은 서로 같거나 다를 수 있고, Y1 내지 Y13은 각각 독립적으로 산소원자, 황원자,
Figure 112015000945008-pat00243
, 또는
Figure 112015000945008-pat00244
이고,
R8 내지 R23, 및 R26 내지 R70은 서로 같거나 다를 수 있고, R8 내지 R23, 및 R26 내지 R70은 각각 독립적으로 수소원자,
Figure 112015000945008-pat00245
,
Figure 112015000945008-pat00246
,
Figure 112015000945008-pat00247
,
Figure 112015000945008-pat00248
, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고, 또는 R8 내지 R23, 및 R26 내지 R70 중 적어도 어느 하나는 그 어느 하나가 결합된 탄소원자의 이웃한 탄소원자와 추가로 결합하여 치환 또는 비치환된 융합된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 융합된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 융합된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 융합된 C1 내지 C30 헤테로 아릴기를 형성할 수 있고,
Ar3 내지 Ar7은 서로 같거나 다를 수 있고, Ar3 내지 Ar7은 각각 독립적으로
Figure 112015000945008-pat00249
,
Figure 112015000945008-pat00250
,
Figure 112015000945008-pat00251
,
Figure 112015000945008-pat00252
, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,
Ar1 및 Ar2는 서로 같거나 다를 수 있고, Ar1 및 Ar2는 각각 독립적으로
Figure 112015000945008-pat00253
,
Figure 112015000945008-pat00254
,
Figure 112015000945008-pat00255
,
Figure 112015000945008-pat00256
,
Figure 112015000945008-pat00257
, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이거나, 또는 Ar1 및 Ar2는 서로 결합되고 그들 사이의 질소원자와 함께 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기를 형성할 수 있고,
X38 내지 X40은 서로 같거나 다를 수 있고, X38 내지 X40은 각각 독립적으로 질소원자, 또는
Figure 112015000945008-pat00258
이고,
Y14 내지 Y17은 서로 같거나 다를 수 있고, Y14 내지 Y17은 각각 독립적으로 산소원자, 황원자,
Figure 112015000945008-pat00259
, 또는
Figure 112015000945008-pat00260
이고,
R71 내지 R116은 서로 같거나 다를 수 있고, R71 내지 R116은 서로 독립적으로 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,
Ar8은 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,
R1 내지 R3, 및 R7은 서로 같거나 다를 수 있고, R1 내지 R3, 및 R7은 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이거나, 또는 R1 내지 R3, 및 R7 중 적어도 어느 하나는 그 어느 하나가 결합된 탄소원자의 이웃한 탄소원자와 추가로 결합하여 치환 또는 비치환된 융합된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 융합된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 융합된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 융합된 C1 내지 C30 헤테로 아릴기를 형성할 수 있다.
An organic electroluminescent device compound represented by the following structural formula 1 or 2, wherein the structural formulas 1 and 2 are represented by the following structural formulas 1-1 and 2-1, respectively.
Figure 112015000945008-pat00218

Figure 112015000945008-pat00219

In the structural formulas 1-1 and 2-1,
R 4 is a hydrogen atom,
R 5 and R 6 may be the same or different from each other, and R 5 and R 6 are each independently
Figure 112015000945008-pat00220
,
Figure 112015000945008-pat00221
,
Figure 112015000945008-pat00222
,
Figure 112015000945008-pat00223
,
Figure 112015000945008-pat00224
,
Figure 112015000945008-pat00225
,
Figure 112015000945008-pat00226
,
Figure 112015000945008-pat00227
,
Figure 112015000945008-pat00228
,
Figure 112015000945008-pat00229
,
Figure 112015000945008-pat00230
,
Figure 112015000945008-pat00231
,
Figure 112015000945008-pat00232
,
Figure 112015000945008-pat00233
,
Figure 112015000945008-pat00234
,
Figure 112015000945008-pat00235
,
Figure 112015000945008-pat00236
,
Figure 112015000945008-pat00237
,
Figure 112015000945008-pat00238
,
Figure 112015000945008-pat00239
,
Figure 112015000945008-pat00240
,
Figure 112015000945008-pat00241
, A substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C1 to C30 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, Or a fused C3 to C30 cycloalkyl group which is further substituted or unsubstituted by at least any one of R 5 and R 6 bonded to the adjacent carbon atom of the carbon atom to which either of R 5 and R 6 is bonded, A substituted or unsubstituted fused C1 to C30 heterocycloalkyl group, a substituted or unsubstituted fused C6 to C30 aryl group, or a substituted or unsubstituted fused C1 to C30 heteroaryl group,
X 1 to X 18 , and X 23 to X 37 may be the same or different from each other, X 1 to X 18 , and X 23 to X 37 each independently represent a nitrogen atom, or
Figure 112015000945008-pat00242
ego,
Y 1 to Y 13 may be the same or different from each other, Y 1 to Y 13 each independently represent an oxygen atom, a sulfur atom,
Figure 112015000945008-pat00243
, or
Figure 112015000945008-pat00244
ego,
R 8 to R 23 , and R 26 to R 70 may be the same or different from each other, and R 8 to R 23 and R 26 to R 70 are each independently a hydrogen atom,
Figure 112015000945008-pat00245
,
Figure 112015000945008-pat00246
,
Figure 112015000945008-pat00247
,
Figure 112015000945008-pat00248
, A substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, Or at least one of R 8 to R 23 and R 26 to R 70 is further bonded to a neighboring carbon atom of a carbon atom to which either of R 8 to R 23 and R 26 to R 70 is bonded to form a substituted or unsubstituted fused Substituted C3 to C30 cycloalkyl groups, substituted or unsubstituted fused C1 to C30 heterocycloalkyl groups, substituted or unsubstituted fused C6 to C30 aryl groups, or substituted or unsubstituted fused C1 to C30 heteroaryl groups Can,
Ar 3 to Ar 7 may be the same or different from each other, Ar 3 to Ar 7 each independently represent
Figure 112015000945008-pat00249
,
Figure 112015000945008-pat00250
,
Figure 112015000945008-pat00251
,
Figure 112015000945008-pat00252
, A substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, RTI ID = 0.0 > Cl-C30 < / RTI > heteroaryl group,
Ar 1 and Ar 2 may be the same or different from each other, Ar 1 and Ar 2 are each independently
Figure 112015000945008-pat00253
,
Figure 112015000945008-pat00254
,
Figure 112015000945008-pat00255
,
Figure 112015000945008-pat00256
,
Figure 112015000945008-pat00257
, A substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, C1 to C30 heteroaryl group, or is Ar 1 and Ar 2 are combined and together with the nitrogen atom between them, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, or form a substituted or unsubstituted C1-C30 heteroaryl each other You can,
X 38 to X 40 may be the same or different from each other, and each of X 38 to X 40 is independently a nitrogen atom or
Figure 112015000945008-pat00258
ego,
Y 14 to Y 17 may be the same or different from each other, Y 14 to Y 17 represents an oxygen atom, a sulfur atom, each independently,
Figure 112015000945008-pat00259
, or
Figure 112015000945008-pat00260
ego,
R 71 to R 116 may be the same or different from each other, and R 71 to R 116 independently represent a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C1 to C30 heteroaryl group,
Ar 8 represents a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, An unsubstituted C1 to C30 heteroaryl group,
R 1 to R 3 and R 7 may be the same or different from each other, and R 1 to R 3 and R 7 are each independently a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 aryl group, C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C1 to C30 heteroaryl group, or R 1 to R 3 and R 7 is a fused C3 to C30 cycloalkyl group, a substituted or unsubstituted fused C1 to C30 heterocycloalkyl group, a substituted or unsubstituted fused substituted or unsubstituted fused C3 to C30 heterocycloalkyl group, A substituted or unsubstituted fused C6 to C30 aryl group, or a substituted or unsubstituted fused C1 to C30 heteroaryl group.
제1항에 있어서,
상기 유기전계발광소자용 화합물은 하기 구조식으로 표시되는 화합물 중에서 선택된 어느 하나인 것을 특징으로 하는 유기전계발광소자용 화합물.
Figure 112015000945008-pat00207

Figure 112015000945008-pat00208

Figure 112015000945008-pat00209

Figure 112015000945008-pat00210

Figure 112015000945008-pat00261

Figure 112015000945008-pat00212

Figure 112015000945008-pat00213

Figure 112015000945008-pat00214

Figure 112015000945008-pat00215

Figure 112015000945008-pat00216

Figure 112015000945008-pat00217
The method according to claim 1,
Wherein the organic electroluminescent device compound is any one selected from compounds represented by the following structural formulas.
Figure 112015000945008-pat00207

Figure 112015000945008-pat00208

Figure 112015000945008-pat00209

Figure 112015000945008-pat00210

Figure 112015000945008-pat00261

Figure 112015000945008-pat00212

Figure 112015000945008-pat00213

Figure 112015000945008-pat00214

Figure 112015000945008-pat00215

Figure 112015000945008-pat00216

Figure 112015000945008-pat00217
제1항 및 제2항 중 어느 하나의 항에 따른 유기전계발광소자용 화합물을 포함하는 유기전계발광소자.An organic electroluminescent device comprising the compound for organic electroluminescent device according to any one of claims 1 and 2. 제1전극, 제2전극 및 제1전극과 제2전극 사이에 단수 또는 복수의 유기물층을 포함하는 유기전계발광소자에 있어서,
상기 단수 또는 복수의 유기물층 중에서 선택된 1종 이상의 유기물층은 제1항 및 제2항 중 어느 하나의 항에 따른 유기전계발광소자용 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.
A first electrode, a second electrode, and a single or a plurality of organic layers between the first electrode and the second electrode, the organic electroluminescent device comprising:
The organic electroluminescent device according to any one of claims 1 to 3, wherein the at least one organic layer selected from the single or plural organic layers comprises the compound for organic electroluminescent devices according to any one of claims 1 and 2.
제4항에 있어서,
상기 단수 또는 복수의 유기물층은 발광층을 포함하는 것을 특징으로 하는 유기전계발광소자.
5. The method of claim 4,
Wherein the single or plural organic layers include a light emitting layer.
제4항에 있어서,
상기 복수의 유기물층은 발광층을 포함하고, 상기 복수의 유기물층은 전자주입층, 전자수송층, 정공차단층, 전자차단층, 정공수송층 및 정공주입층 중에서 선택된 1종 이상을 추가로 포함하는 것을 특징으로 하는 유기전계발광소자.
5. The method of claim 4,
Wherein the plurality of organic layers include a light emitting layer and the plurality of organic layers further include at least one selected from an electron injecting layer, an electron transporting layer, a hole blocking layer, an electron blocking layer, a hole transporting layer and a hole injecting layer Organic electroluminescent device.
제5항에 있어서,
상기 발광층은 호스트와 도펀트를 포함하는 것을 특징으로 하는 유기전계발광소자.
6. The method of claim 5,
Wherein the light emitting layer comprises a host and a dopant.
KR1020120151964A 2012-06-04 2012-12-24 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same KR101527181B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/KR2013/002321 WO2013183851A1 (en) 2012-06-04 2013-03-21 Novel organic electroluminescent element compound and organic electroluminescent element comprising same
CN201380038179.3A CN104471021B (en) 2012-06-04 2013-03-21 Novel organic electroluminescent element compound and organic electroluminescent element comprising same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20120059643 2012-06-04
KR1020120059643 2012-06-04
KR1020120118447A KR20130136359A (en) 2012-06-04 2012-10-24 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR1020120118447 2012-10-24

Publications (2)

Publication Number Publication Date
KR20130136366A KR20130136366A (en) 2013-12-12
KR101527181B1 true KR101527181B1 (en) 2015-06-09

Family

ID=49983200

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020120118447A KR20130136359A (en) 2012-06-04 2012-10-24 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR1020120151964A KR101527181B1 (en) 2012-06-04 2012-12-24 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020120118447A KR20130136359A (en) 2012-06-04 2012-10-24 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same

Country Status (2)

Country Link
KR (2) KR20130136359A (en)
CN (1) CN104471021B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102184893B1 (en) * 2013-12-04 2020-12-01 롬엔드하스전자재료코리아유한회사 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
KR102411748B1 (en) * 2014-03-17 2022-06-23 롬엔드하스전자재료코리아유한회사 Electron Buffering Material and Organic Electroluminescent Device
KR102427918B1 (en) * 2014-04-29 2022-08-03 롬엔드하스전자재료코리아유한회사 Electron transport material and an organic electroluminescence device comprising the same
KR102330221B1 (en) 2014-11-05 2021-11-25 삼성디스플레이 주식회사 Organic light emitting device and display having the same
WO2016078747A1 (en) 2014-11-21 2016-05-26 Merck Patent Gmbh Heterocyclic compounds for use in electronic devices
KR102624166B1 (en) * 2015-06-15 2024-01-12 삼성디스플레이 주식회사 Organic electroluminescence device
CN105418485B (en) * 2015-12-22 2019-04-19 吉林奥来德光电材料股份有限公司 A kind of new green light host compound and its preparation method and application
WO2017142304A1 (en) * 2016-02-15 2017-08-24 주식회사 엘지화학 Heterocyclic compound and organic electroluminescent device comprising same
JP6705586B2 (en) * 2016-02-15 2020-06-03 エルジー・ケム・リミテッド Heterocyclic compound and organic electroluminescent device containing the same
KR101924086B1 (en) * 2016-02-26 2018-11-30 삼성에스디아이 주식회사 Organic compound, organic optoelectric device and display device
CN106674210A (en) * 2016-12-23 2017-05-17 江苏三月光电科技有限公司 Organic compounds using homobenzenes as core and application thereof in organic electroluminescent devices
CN107089990B (en) * 2017-06-07 2019-12-03 江苏三月光电科技有限公司 It is a kind of using fluorenes as the organic compound of core and its application on organic electroluminescence device
CN110386923B (en) * 2018-04-19 2022-05-27 北京鼎材科技有限公司 Carbazole compound, application thereof and organic electroluminescent device
CN111138418B (en) * 2018-11-02 2022-11-08 北京绿人科技有限责任公司 Organic heterocyclic compound, application thereof and organic electroluminescent device
KR102649286B1 (en) * 2019-05-03 2024-03-19 덕산네오룩스 주식회사 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR102080737B1 (en) * 2019-05-29 2020-02-24 (주)피엔에이치테크 An electroluminescent compound and an electroluminescent device comprising the same
CN111039930A (en) * 2019-09-12 2020-04-21 广东工业大学 bis-N-phenyl-3-carbazole substituted phenanthroimidazole compound, preparation method thereof and application thereof as electroluminescent device
CN111217739A (en) * 2020-02-19 2020-06-02 烟台显华化工科技有限公司 Organic compound, organic electroluminescent device comprising organic compound and display device comprising organic compound
KR20230174709A (en) * 2022-06-20 2023-12-28 (주)피엔에이치테크 Organic compound and electroluminescent device comprising the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110117548A (en) * 2010-04-21 2011-10-27 덕산하이메탈(주) Compound containing dibenzothiophene, arylamine derivatives and organic electronic element using the same, terminal thereof
WO2011133007A2 (en) * 2010-04-23 2011-10-27 Cheil Industries Inc. Compound for optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode
JP2012049518A (en) * 2010-07-27 2012-03-08 Konica Minolta Holdings Inc Material for organic electroluminescent element, compound, organic electroluminescent element, display device, and luminaire
WO2012046560A1 (en) * 2010-10-04 2012-04-12 Semiconductor Energy Laboratory Co., Ltd. Composite material, light-emitting element, light-emitting device, electronic device, and lighting device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4590825B2 (en) * 2003-02-21 2010-12-01 コニカミノルタホールディングス株式会社 White light emitting organic electroluminescence device
JP2009057307A (en) * 2007-08-31 2009-03-19 Toyo Ink Mfg Co Ltd Compound having carbazolyl group, and use of the same
JP2009120582A (en) * 2007-10-26 2009-06-04 Toyo Ink Mfg Co Ltd Carbazolyl group-bearing compound and use of the same
KR101183722B1 (en) * 2009-12-30 2012-09-17 주식회사 두산 Triphenylene-based compounds and organic electroluminescent device comprising same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110117548A (en) * 2010-04-21 2011-10-27 덕산하이메탈(주) Compound containing dibenzothiophene, arylamine derivatives and organic electronic element using the same, terminal thereof
WO2011133007A2 (en) * 2010-04-23 2011-10-27 Cheil Industries Inc. Compound for optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode
JP2012049518A (en) * 2010-07-27 2012-03-08 Konica Minolta Holdings Inc Material for organic electroluminescent element, compound, organic electroluminescent element, display device, and luminaire
WO2012046560A1 (en) * 2010-10-04 2012-04-12 Semiconductor Energy Laboratory Co., Ltd. Composite material, light-emitting element, light-emitting device, electronic device, and lighting device

Also Published As

Publication number Publication date
KR20130136359A (en) 2013-12-12
KR20130136366A (en) 2013-12-12
CN104471021B (en) 2017-05-24
CN104471021A (en) 2015-03-25

Similar Documents

Publication Publication Date Title
KR101527181B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101521790B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101593465B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101447961B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101447959B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101550429B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101584753B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101499102B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20140091487A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101468493B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101626523B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101401631B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101480125B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101401633B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150012974A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101401620B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150022615A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150059680A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20140004549A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101396552B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101562883B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101576921B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150037133A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101562882B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101516279B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20190603

Year of fee payment: 5